Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2014	Jul. 31, 2014 Class A	Jul. 31, 2014 Class B	Jul. 31, 2014 Class C	Jul. 31, 2014 Class D
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q2
Trading Symbol	UHS
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		6,595,708	91,871,243	664,000	29,205

Condensed Consolidated Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Net revenues before provision for doubtful accounts	$ 2,195,776	$ 2,081,662	$ 4,324,126	$ 4,160,010
Less: Provision for doubtful accounts	175,955	246,687	384,139	493,403
Net revenues	2,019,821	1,834,975	3,939,987	3,666,607
Operating charges:
Salaries, wages and benefits	961,920	897,334	1,897,285	1,799,630
Other operating expenses	428,720	325,562	810,480	706,569
Supplies expense	223,774	202,344	439,572	406,986
Depreciation and amortization	90,691	81,682	184,050	161,494
Lease and rental expense	23,458	24,082	46,796	48,747
Electronic health records incentive income	(2,174)	(83)	(2,604)	(4,795)
Operating Expenses, Total	1,726,389	1,530,921	3,375,579	3,118,631
Income from operations	293,432	304,054	564,408	547,976
Interest expense, net	35,087	38,236	70,280	78,174
Income before income taxes	258,345	265,818	494,128	469,802
Provision for income taxes	91,731	98,015	175,662	172,064
Net income	166,614	167,803	318,466	297,738
Less: Income attributable to noncontrolling interests	14,943	15,962	28,717	26,113
Net income attributable to UHS	$ 151,671	$ 151,841	$ 289,749	$ 271,625
Basic earnings per share attributable to UHS	$ 1.53	$ 1.55	$ 2.93	$ 2.77
Diluted earnings per share attributable to UHS	$ 1.51	$ 1.53	$ 2.89	$ 2.75
Weighted average number of common shares - basic	98,872	98,033	98,722	97,872
Add: Other share equivalents	1,363	1,178	1,474	1,019
Weighted average number of common shares and equivalents - diluted	100,235	99,211	100,196	98,891

Condensed Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Net income	$ 166,614	$ 167,803	$ 318,466	$ 297,738
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges	4,465	5,282	8,210	9,817
Amortization of terminated hedge	(84)	(84)	(168)	(168)
Other comprehensive income before tax	4,381	5,198	8,042	9,649
Income tax expense related to items of other comprehensive income	1,620	1,960	2,974	3,638
Total other comprehensive income, net of tax	2,761	3,238	5,068	6,011
Comprehensive income	169,375	171,041	323,534	303,749
Less: Comprehensive income attributable to noncontrolling interests	14,943	15,962	28,717	26,113
Comprehensive income attributable to UHS	$ 154,432	$ 155,079	$ 294,817	$ 277,636

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 14,732	$ 17,238	$ 12,558	$ 23,471
Accounts receivable, net	1,186,012	1,116,961
Supplies	104,280	101,781
Deferred income taxes	107,359	119,903
Other current assets	117,498	76,446
Total current assets	1,529,881	1,432,329
Property and equipment	5,901,163	5,691,902
Less: accumulated depreciation	(2,386,484)	(2,249,733)
Property, plant and equipment, net, Total	3,514,679	3,442,169
Other assets:
Goodwill	3,089,172	3,049,016
Deferred charges	48,976	57,881
Other	365,364	330,328
Total assets	8,548,072	8,311,723	8,317,253
Current liabilities:
Current maturities of long-term debt	77,686	99,312
Accounts payable and accrued liabilities	1,038,187	953,449
Federal and state taxes	0	7,127
Total current liabilities	1,115,873	1,059,888
Other noncurrent liabilities	276,462	284,589
Long-term debt	3,070,311	3,209,762
Deferred income taxes	254,573	239,148
Redeemable noncontrolling interests	231,545	218,107
Equity:
UHS common stockholders' equity	3,546,134	3,249,979
Noncontrolling interest	53,174	50,250
Total equity	3,599,308	3,300,229
Liabilities and Equity, Total	$ 8,548,072	$ 8,311,723

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash Flows from Operating Activities:
Net income	$ 318,466	$ 297,738
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization	184,050	161,677
Stock-based compensation expense	14,945	13,579
Gains on sales of assets and businesses, net of losses	(10,134)	(2,277)
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(61,865)	(82,224)
Accrued interest	(271)	13,199
Accrued and deferred income taxes	(9,435)	3,280
Other working capital accounts	17,739	32,421
Other assets and deferred charges	10,415	9,069
Other	(4,092)	4,083
Accrued insurance expense, net of commercial premiums paid	38,520	(22,590)
Payments made in settlement of self-insurance claims	(39,922)	(37,038)
Net cash provided by operating activities	458,416	390,917
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(186,786)	(175,944)
Proceeds received from sale of assets and businesses	11,450	34,008
Cash paid/reserved related to acquisition of property and businesses	(71,000)	(1,320)
Costs incurred for purchase and implementation of electronic health records application	(8,399)	(33,396)
Net cash provided by (used in) investing activities	(254,735)	(176,652)
Cash Flows from Financing Activities:
Reduction of long-term debt	(179,126)	(196,096)
Additional borrowings	0	11,000
Repurchase of common shares	(35,773)	(21,373)
Dividends paid	(9,884)	(9,795)
Issuance of common stock	3,287	2,735
Excess income tax benefits related to stock-based compensation	28,493	15,085
Profit distributions to noncontrolling interests	(13,184)	(26,734)
Net cash (used in) provided by financing activities	(206,187)	(225,178)
Decrease in cash and cash equivalents	(2,506)	(10,913)
Cash and cash equivalents, beginning of period	17,238	23,471
Cash and cash equivalents, end of period	14,732	12,558
Supplemental Disclosures of Cash Flow Information:
Interest paid	60,078	54,067
Income taxes paid, net of refunds	$ 156,434	$ 152,553

General

6 Months Ended

Jun. 30, 2014

General

(1) General

This Quarterly Report on Form 10-Q is for the quarterly period ended June 30, 2014. In this Quarterly Report, “we,” “us,” “our” “UHS” and the “Company” refer to Universal Health Services, Inc. and its subsidiaries.

The condensed consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships and limited liability companies controlled by us, or our subsidiaries, as managing general partner or managing member. The condensed consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments (consisting only of normal recurring adjustments) which, in our opinion, are necessary to fairly state results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements, significant accounting policies and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013.

Relationship with Universal Health Realty Income Trust and Related Party Transactions

6 Months Ended

Jun. 30, 2014

Relationship with Universal Health Realty Income Trust and Related Party Transactions

(2) Relationship with Universal Health Realty Income Trust and Related Party Transactions

Relationship with Universal Health Realty Income Trust:

At June 30, 2014, we held approximately 6.1% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying condensed consolidated statements of income, of approximately $600,000 during each of the three-month periods ended June 30, 2014 and 2013, and approximately $1.2 million during each of the six-month periods ended June 30, 2014 and 2013. Our pre-tax share of income from the Trust was $100,000 and $200,000 during the three-month periods ended June 30, 2014 and 2013, respectively, and $400,000 and $500,000 for the six-month periods ended June 30, 2014 and 2013, respectively. The carrying value of this investment was approximately $8 million at each of June 30, 2014 and December 31, 2013, and is included in other assets in the accompanying condensed consolidated balance sheets. The market value of this investment, based on the closing price of the Trust’s stock on the respective dates, was approximately $34 million at June 30, 2014 and $32 million at December 31, 2013.

Total rent expense under the operating leases on the hospital facilities with the Trust was approximately $4.0 million during each of the three-month periods ended June 30, 2014 and 2013, and approximately $8.0 million for each of the six-month periods ended June 30, 2014 and 2013. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by limited liability companies in which the Trust holds either 100% ownership interests or non-controlling majority ownership interests.

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Other Related Party Transactions:

In December, 2010, our Board of Directors approved the Company’s entering into supplemental life insurance plans and agreements on the lives of our chief executive officer and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums and certain trusts, owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2013 or the first six months of 2014.

A member of our Board of Directors and member of the Executive Committee is Of Counsel to Norton Rose Fulbright, one of the law firms used by us as outside counsel. This Board member is also the trustee of certain trusts for the benefit of our Chief Executive Officer (“CEO”) and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References+ Details

Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

6 Months Ended

Jun. 30, 2014

Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

(3) Other Noncurrent liabilities and Redeemable/Noncontrolling Interests

Other noncurrent liabilities include the long-term portion of our professional and general liability, workers’ compensation reserves and pension liability.

Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in our five acute care facilities located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania. The redeemable noncontrolling interest balances of $232 million and $218 million as of June 30, 2014 and December 31, 2013, respectively, and the noncontrolling interest balances of $53 million and $50 million as of June 30, 2014 and December 31, 2013, respectively, consist primarily of the third-party ownership interests in these hospitals.

In connection with the five acute care facilities located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain “put rights”, that are currently exercisable, that if exercised, require us to purchase the minority member’s interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member’s ownership percentage is reduced to less than certain thresholds. In connection with the behavioral health care facility located in Philadelphia, Pennsylvania, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a “put option” to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member’s interest at fair market value. As of June 30, 2014, we believe the fair market value of the minority ownership interests in these facilities, pursuant to the terms of the put options, approximates the book value of the redeemable noncontrolling interests.

Long-term debt and cash flow hedges

6 Months Ended

Jun. 30, 2014

Long-term debt and cash flow hedges

(4) Long-term debt and cash flow hedges

Credit Facilities and Outstanding Debt Securities

Subsequent to June 30, 2014 financing events:

Subsequent to June 30, 2014, we completed the following previously disclosed financing transactions:

•

Entered into an amended and restated credit agreement which became effective on August 7, 2014 among UHS, the lenders party thereto and JPMorgan Chase Bank, N.A. as administrative agent. This amended and restated credit agreement, which is scheduled to mature in August, 2019 and the other terms of which are substantially unchanged from our existing Credit Agreement, as discussed below, consists of: (i) an $800 million revolving credit facility, and; (ii) a $1.774 billion Term Loan A facility;

•

Combined our previous term loan A and term loan A2 facilities, which were scheduled to mature in 2016, into the above-mentioned $1.774 billion Term Loan A facility that is scheduled to mature in August, 2019;

•

Repaid $550 million of outstanding borrowings pursuant to our previous term loan B facility which was scheduled to mature in 2016;

•

Increased the borrowing capacity on our existing $275 million accounts receivable securitization program (“Securitization”) to $360 million effective August 1, 2014. The Securitization, the terms of which remain the same as the previous agreement, as discussed below, is scheduled to mature on October 25, 2016;

•

Issued $300 million aggregate principal amount of 3.750% senior secured notes due in 2019 (a);

•

Issued $300 million aggregate principal amount of 4.750% senior secured notes due in 2022 (a);

•

Repaid our previously outstanding $250 million, 7.00% senior unsecured notes due in 2018 which we redeemed on July 31, 2014 for an aggregate price equal to 104.56% of the principal amount.

(a)

The $300 million, 3.750% senior secured notes and the $300 million, 4.750% senior secured notes, which were finalized on August 7, 2014, were offered only to qualified institutional buyers under Rule 144A and to non-U.S. persons outside of the United States in reliance on Regulation S under the Securities Act, as amended (the “Securities Act”). These senior secured notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

In connection with these transactions, during the third quarter of 2014, we expect to incur a charge for costs related to extinguishment of debt primarily related to the write-off of deferred charges on the extinguished debt as well as the make-whole premium paid on the redemption of the $250 million, 7% unsecured notes.

Debt (existing as of June 30, 2014):

Pursuant to the terms of our previous Credit Agreement and related amendments (among UHS, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as administrative agent and the other agents party thereto), which was replaced in August, 2014 with the amended and restated credit agreement, as outlined above, as of June 30, 2014 we had:

•

$913 million of borrowings outstanding pursuant to our term loan A facility;

•

$861 million of borrowings outstanding pursuant to our term loan A2 facility;

•

$550 million of borrowing outstanding pursuant to our term loan B facility, and;

•

$0 borrowings outstanding pursuant to our revolving credit facility.

Borrowings under the Credit Agreement bear interest at either (1) the ABR rate which is defined as the rate per annum equal to, at our election: the greatest of (a) the lender’s prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month LIBOR rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit, term loan-A and term loan-A2 borrowings and 1.25% for term loan B borrowings or (2) the one, two, three or six month LIBOR rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit, term loan-A and term loan-A2 borrowings and 2.25% for term loan-B borrowings. As of June 30, 2014, the applicable margins were 0.50% for ABR-based loans, 1.50% for LIBOR-based loans under the revolving credit, term loan-A and term loan-A2 facilities and 2.25% under the term loan-B facility.

As of June 30, 2014, we had no outstanding borrowings pursuant to the terms of our $800 million revolving credit facility and we had $776 million of available borrowing capacity, net of $4 million of outstanding borrowings pursuant to a short-term, on-demand credit facility and $20 million of outstanding letters of credit. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by substantially all of the assets of the Company and our material subsidiaries and guaranteed by our material subsidiaries.

We made scheduled principal payments of $18 million on the term loan-A and term loan A2 facilities during each of the three-month periods ended June 30, 2014 and 2013, and $36 million on the term loan-A and term loan A2 facilities during each of the six-month periods ended June 30, 2014 and 2013. Quarterly installment payments are due on the new term loan-A facility which commence in the fourth quarter of 2014 and will approximate $11 million per quarter through September, 2016 (at which time they increase to $22 million per quarter).

As discussed above, on August 1, 2014, our accounts receivable securitization program (“Securitization”), with a group of conduit lenders and liquidity banks which is scheduled to mature on October 25, 2016, was amended to increase the borrowing capacity to $360 million from $275 million. Substantially all of the patient-related accounts receivable of our acute care hospitals (“Receivables”) serve as collateral for the outstanding borrowings. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At June 30, 2014, we had $130 million of outstanding borrowings and $145 million of additional capacity pursuant to the terms of our accounts receivable securitization program.

Our $250 million, 7.00% senior unsecured notes (the “Unsecured Notes”), which were scheduled to mature on October 1, 2018, were redeemed by us on July 31, 2014 at 104.56%. The Unsecured Notes were issued on September 29, 2010 and registered in April, 2011. Interest on the Unsecured Note was payable semiannually in arrears on April 1st and October 1st of each year. The Unsecured Notes were redeemable by us in whole, at anytime, subject to a make-whole premium of the applicable treasury rate plus 50 basis points prior to October 1, 2014.

On June 30, 2006, we issued $250 million of senior notes which have a 7.125% coupon rate and mature on June 30, 2016 (the “7.125% Notes”). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006.

In connection with entering into the previous Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2016) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates and dividends; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of June 30, 2014.

As of June 30, 2014, the carrying value of our debt was $3.15 billion and the fair-value of our debt was $3.20 billion. The fair value of our debt was computed based upon quotes received from financial institutions and we consider these to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with debt instruments.

Cash Flow Hedges:

We manage our ratio of fixed and floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within shareholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge’s inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2013 and the first six months of 2014 and determined the hedges to be highly effective. We also determined that any portion of the hedges deemed to be ineffective was de minimis and therefore there was no material effect on our consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. However, at June 30, 2014, each swap agreement entered into by us was in a net liability position which would require us to make the net settlement payments to the counterparties. We do not anticipate nonperformance by our counterparties. We do not hold or issue derivative financial instruments for trading purposes.

We entered into six forward starting interest rate swaps in the first quarter of 2011 whereby we pay a fixed rate on a total notional amount of $425 million and receive three-month LIBOR. Three of these swaps with a total notional amount of $225 million became effective in March, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 1.91%. The three remaining interest rate swaps with total notional amounts of $100 million, $25 million and $75 million became effective in December, 2011 and have/had fixed rates of 2.50%, 1.96% and 1.32%, and maturity dates in December, 2014, December, 2013 and December, 2012, respectively.

During the fourth quarter of 2010, we entered into four forward starting interest rate swaps whereby we pay a fixed rate on a total notional amount of $600 million and receive three-month LIBOR. Each of the four swaps became effective in December, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 2.38%.

We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was an aggregate gross and net liability of $16 million at June 30, 2014, which is included in accounts payable and accrued liabilities on the accompanying balance sheet. The fair value of our interest rate swaps was an aggregate gross and net liability of $24 million at December 31, 2013, of which $19 million was included in accounts payable and accrued liabilities and $5 million was included in other noncurrent liabilities on the accompanying balance sheet.

Commitments and Contingencies

6 Months Ended

Jun. 30, 2014

Commitments and Contingencies

(5) Commitments and Contingencies

Professional and General Liability and Workers Compensation Liability:

Effective November, 2010, excluding our subsidiaries acquired as a result of our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010, our subsidiaries are self-insured for professional and general liability exposure up to $10 million and $3 million per occurrence, respectively. Since our acquisition of PSI in November, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence. Our subsidiaries (including the former PSI subsidiaries) were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $250 million per occurrence and in the aggregate. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate. The 9 behavioral health facilities acquired from Ascend Health Corporation in October, 2012 have general and professional liability policies through commercial insurance carriers which provide for up to $20 million of aggregate coverage, subject to a $25,000 per occurrence deductible. These facilities, like our other facilities, are also provided excess coverage through commercial insurance carriers for coverage in excess of the underlying commercial policy limitations up to $250 million per occurrence and in the aggregate.

Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

During the second quarter of 2013, pursuant to a reserve analysis, we recorded reductions to our professional and general liability self-insurance reserves (relating to years prior to 2013) amounting to $65 million in the aggregate. The favorable changes in our estimated future claims payments relating to years prior to 2013 were due to: (i) an increased weighting given to company-specific metrics (to 100% from 75%), and decreased general industry metrics (to 0% from 25%), related to projected incidents per exposure, historical claims experience and loss development factors; (ii) historical data which measured the realized favorable impact of medical malpractice tort reform experienced in several states in which we operate, and; (iii) a decrease in claims related to certain higher risk specialties (such as obstetrical) due to a continuation of the company-wide patient safety initiative undertaken during the last several years. As the number of our facilities and our patient volumes have increased, thereby providing for a statistically significant data group, and taking into consideration our long-history of company-specific risk management programs and claims experience, our reserve analyses have included a greater emphasis on our historical professional and general liability experience which has developed favorably as compared to general industry trends.

As of June 30, 2014, the total accrual for our professional and general liability claims was $204 million, of which $44 million is included in current liabilities. As of December 31, 2013, the total accrual for our professional and general liability claims was $206 million, of which $44 million is included in current liabilities.

As of June 30, 2014, the total accrual for our workers’ compensation liability claims was $64 million, of which $34 million is included in current liabilities. As of December 31, 2013, the total accrual for our workers’ compensation liability claims was $64 million, of which $34 million is included in current liabilities

Property Insurance:

We have commercial property insurance policies covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a $250,000 deductible for the majority of our properties (the properties acquired from PSI are subject to a $50,000 deductible). Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million, subject to a $25,000 deductible. Non-critical flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility. Since certain of our facilities have been designated by our insurer as flood prone, we have elected to purchase policies from The National Flood Insurance Program to cover a substantial portion of the applicable deductible.

Other

Our accounts receivable as of June 30, 2014 and December 31, 2013 include amounts due from Illinois of approximately $28 million and $49 million, respectively. Collection of the outstanding receivables continues to be delayed due to state budgetary and funding pressures. Approximately $5 million as of June 30, 2014 and $28 million as of December 31, 2013, of the receivables due from Illinois were outstanding in excess of 60 days, as of each respective date. In addition, our accounts receivable as of June 30, 2014 and December 31, 2013 includes approximately $32 million and $46 million due from Texas in connection with Medicaid supplemental payment programs (which we expect to collect during 2014). Although the accounts receivable due from Illinois and Texas could remain outstanding for the foreseeable future, since we expect to eventually collect all amounts due to us, no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois and/or Texas. Failure to ultimately collect all outstanding amounts due from these states would have an adverse impact on our future consolidated results of operations and cash flows;

As of June 30, 2014 we were party to certain off balance sheet arrangements consisting of standby letters of credit and surety bonds which totaled $94 million consisting of: (i) $73 million related to our self-insurance programs, and; (ii) $21 million of other debt and public utility guarantees.

Legal Proceedings

We are subject to claims and suits in the ordinary course of business, including those arising from care and treatment afforded by our hospitals and are party to litigation, as outlined below.

Office of Inspector General (“OIG”) and Other Government Investigations

In September, 2010, we, along with many other companies in the healthcare industry, received a letter from the United States Department of Justice (“DOJ”) advising of a False Claim Act investigation being conducted in connection with the implantation of implantable cardioverter defibrillators (“ICDs”) from 2003 to 2010 at several of our acute care facilities. The DOJ alleges that ICDs were implanted and billed by our facilities in contravention of a National Coverage Determination regarding these devices. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements.

In February, 2013, the OIG served a subpoena requesting various documents from January, 2008 to the date of the subpoena directed at Universal Health Services, Inc. (“UHS”) concerning it and UHS of Delaware, Inc., and several UHS owned behavioral health facilities including: Keys of Carolina, Old Vineyard Behavioral Health, The Meadows Psychiatric Center, Streamwood Behavioral Health, Hartgrove Hospital, Rock River Academy and Residential Treatment Center, Roxbury Treatment Center, Harbor Point Behavioral Health Center, f/k/a, The Pines Residential Treatment Center, including the Crawford, Brighton and Kempsville campuses, Wekiva Springs Center and River Point Behavioral Health. Prior to receiving this subpoena: (i) the Keys of Carolina and Old Vineyard received notification during the second half of 2012 from the United States Department of Justice of its intent to proceed with an investigation following requests for documents for the period of January, 2007 to the date of the subpoenas from the North Carolina state Attorney General’s Office; (ii) Harbor Point Behavioral Health Center received a subpoena in December, 2012 from the Attorney General of the Commonwealth of Virginia requesting various documents from July, 2006 to the date of the subpoena, and; (iii) The Meadows Psychiatric Center received a subpoena from the OIG in February, 2013 requesting certain documents from 2008 to the date of the subpoena. Unrelated to these matters, the Keys of Carolina was closed and the real property was sold in January, 2013. We were advised that a qui tam action had been filed against Roxbury Treatment Center but the government declined to intervene and the case was dismissed.

In April, 2013, the OIG served facility specific subpoenas on Wekiva Springs Center and River Point Behavioral Health requesting various documents from January, 2005 to the date of the subpoenas. In July, 2013, another subpoena was issued to Wekiva Springs Center and River Point Behavioral Health requesting additional records. In October, 2013, we were advised by the DOJ’s Criminal Frauds Section that they received a referral from the DOJ Civil Division and opened an investigation of River Point Behavioral Health and Wekiva Springs Center. Subsequent subpoenas have since been issued to River Point Behavioral Health and Wekiva Springs Center requesting additional documentation. In April, 2014, the Centers for Medicare and Medicaid Services (“CMS”) instituted a Medicare payment suspension at River Point Behavioral Health in accordance with federal regulations which implemented provisions of the Affordable Care Act regarding suspension of payments during certain investigations. The Florida Agency for Health Care Administration subsequently issued a Medicaid payment suspension for the facility. River Point Behavioral Health submitted a rebuttal statement disputing the basis of the suspension and requesting revocation of the suspension. In response, CMS has continued the payment suspension. River Point Behavioral Health has provided additional information to CMS in an effort to obtain relief from the payment suspension but the suspension remains in effect. We cannot predict if and/or when the facility’s suspended payments will resume. However, if continued for a significant period of time, the payment suspension will likely have a material adverse effect on River Point Behavioral Health’s future results of operations and financial condition. The operating results of River Point Behavioral Health did not have a material impact on our consolidated results of operations for the three and six-month periods ended June 30, 2014 or the year ended December 31, 2013.

In February, 2014, we were notified that the investigation conducted by the Criminal Frauds Section had been expanded to include the National Deaf Academy. In March, 2014, a Civil Investigative Demand (“CID”) was served on the National Deaf Academy requesting documents and information from the facility from January 1, 2008 through the date of the CID. We have been advised by the government that the National Deaf Academy has been added to the facilities which are the subject of the coordinated investigation referenced above.

In March, 2014, CIDs were served on Hartgrove Hospital, Rock River Academy and Streamwood Behavioral Health requesting documents and information from those facilities from January 2008 through the date of the CID.

In June, 2013, the OIG served a subpoena on Coastal Harbor Health System in Savannah, Georgia requesting documents from January, 2009 to the date of the subpoena.

At present, we are uncertain as to the specific focus, scope or extent of the investigations, liability of the facilities and/or potential financial exposure, if any, in connection with these matters.

Matters Relating to PSI:

The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of Psychiatric Solutions, Inc.) which were in existence prior to the acquisition of PSI and for which we have assumed the defense as a result of our acquisition which was completed in November, 2010:

Garden City Employees’ Retirement System v. PSI:

This is a shareholder class action lawsuit filed in the United States District Court for the Middle District of Tennessee against PSI and the former directors in 2009 alleging violations of federal securities laws. We continue to defend the case vigorously. Should we be deemed liable in this matter, or enter into a settlement, we believe we would be entitled to commercial insurance recoveries for at least a portion of amounts paid by us, subject to certain limitations and deductibles. Included in our consolidated balance sheets as of June 30, 2014, including an increase to the estimated reserve recorded during the second quarter of 2014 that did not have a material impact on our financial statements, is an estimated reserve (current liability) of $25 million and commercial insurance recoveries (current asset) of $20 million. Trial is scheduled to begin in mid-September, 2014. Although we cannot predict the outcome, it is possible the commercial insurance recoveries may not be sufficient to cover the ultimate disposition of this matter (including related legal fees) which would make us liable for a potentially material excess amount.

Department of Justice Investigation of Friends Hospital:

In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents have been collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July 2011 requesting additional documents, which have been collected and delivered to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Department of Justice Investigation of Riveredge Hospital:

In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

General:

The healthcare industry is subject to numerous laws and regulations which include, among other things, matters such as government healthcare participation requirements, various licensure, certifications, and accreditations, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government action has increased with respect to investigations and/or allegations concerning possible violations of fraud and abuse and false claims statutes and/or regulations by healthcare providers. Currently, and from time to time, some of our facilities are subjected to inquiries and/or actions and receive notices of potential non-compliance of laws and regulations from various federal and state agencies. Providers that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to potential licensure, certification, and/or accreditation revocation, subjected to payment suspension, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. We monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigation or litigation may result in interpretations that are inconsistent with industry practices, including ours. Although we believe our policies, procedures and practices comply with governmental regulations, there is no assurance that we will not be faced with sanctions, fines or penalties in connection with such inquiries or actions, including with respect to the investigations and other matters discussed herein. Even if we were to ultimately prevail, such inquiries and/or actions could have a material adverse effect on us.

The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation.

In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations.

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

Segment Reporting

6 Months Ended

Jun. 30, 2014

Segment Reporting

(6) Segment Reporting

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of the Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents of each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2013.


	Three months ended June 30, 2014
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
				(Amounts in thousands)
Gross inpatient revenues	$	3,724,309		$	1,686,512			—		$	5,410,821
Gross outpatient revenues	$	2,068,076		$	204,480		$	8,335		$	2,280,891
Total net revenues	$	1,024,011		$	992,348		$	3,462		$	2,019,821
Income/(loss) before allocation of corporate overhead and income taxes	$	118,345		$	243,540		($	103,540	)	$	258,345
Allocation of corporate overhead	($	44,693	)	($	23,136	)	$	67,829			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	73,652		$	220,404		($	35,711	)	$	258,345
Total assets as of 6/30/14	$	3,319,048		$	4,995,534		$	233,490		$	8,548,072


	Six months ended June 30, 2014
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	7,600,673		$	3,295,411			—		$	10,896,084
Gross outpatient revenues	$	4,025,567		$	388,595		$	16,849		$	4,431,011
Total net revenues	$	1,995,400		$	1,937,805		$	6,782		$	3,939,987
Income/(loss) before allocation of corporate overhead and income taxes	$	229,994		$	464,688		($	200,554	)	$	494,128
Allocation of corporate overhead	($	89,390	)	($	49,305	)	$	138,695			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	140,604		$	415,383		($	61,859	)	$	494,128
Total assets as of 6/30/14	$	3,319,048		$	4,995,534		$	233,490		$	8,548,072

	Three months ended June 30, 2013
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,321,154		$	1,598,383			—		$	4,919,537
Gross outpatient revenues	$	1,708,200		$	193,703		$	10,625		$	1,912,528
Total net revenues	$	894,639		$	929,470		$	10,866		$	1,834,975
Income/(loss) before allocation of corporate overhead and income taxes	$	118,390		$	240,556		($	93,128	)	$	265,818
Allocation of corporate overhead	($	46,109	)	($	22,461	)	$	68,570			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	72,281		$	218,095		($	24,558	)	$	265,818
Total assets as of 6/30/13	$	3,126,223		$	4,919,566		$	271,464		$	8,317,253


	Six months ended June 30, 2013
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	6,828,424		$	3,174,531			—		$	10,002,955
Gross outpatient revenues	$	3,359,775		$	379,505		$	21,473		$	3,760,753
Total net revenues	$	1,803,373		$	1,839,014		$	24,220		$	3,666,607
Income/(loss) before allocation of corporate overhead and income taxes	$	199,019		$	461,331		($	190,548	)	$	469,802
Allocation of corporate overhead	($	92,221	)	($	44,828	)	$	137,049			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	106,798		$	416,503		($	53,499	)	$	469,802
Total assets as of 6/30/13	$	3,126,223		$	4,919,566		$	271,464		$	8,317,253

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation

6 Months Ended

Jun. 30, 2014

Earnings Per Share Data ("EPS") and Stock Based Compensation

(7) Earnings Per Share Data (“EPS”) and Stock Based Compensation

Basic earnings per share are based on the weighted average number of common shares outstanding during the period. Diluted earnings per share are based on the weighted average number of common shares outstanding during the period adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):


	Three months ended						Six months ended
	June 30,						June 30,
	2014			2013			2014			2013
	(amounts in thousands)
Basic and Diluted:
Net income attributable to UHS	$	151,671		$	151,841		$	289,749		$	271,625
Less: Net income attributable to unvested restricted share grants		(77	)		(88	)		(147	)		(157	)

Net income attributable to UHS – basic and diluted	$	151,594		$	151,753		$	289,602		$	271,468

Weighted average number of common shares—basic		98,872			98,033			98,722			97,872
Net effect of dilutive stock options and grants based on the treasury stock method		1,363			1,178			1,474			1,019

Weighted average number of common shares and equivalents—diluted		100,235			99,211			100,196			98,891

Earnings per basic share attributable to UHS:	$	1.53		$	1.55		$	2.93		$	2.77

Earnings per diluted share attributable to UHS:	$	1.51		$	1.53		$	2.89		$	2.75

The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all periods presented above, excludes certain outstanding stock options applicable to each period since the effect would have been anti-dilutive. There were no significant anti-dilutive stock options during the three and six months ended June 30, 2014 and June 30, 2013. All classes of our common stock have the same dividend rights.

Stock-Based Compensation: During the three-month periods ended June 30, 2014 and 2013, compensation cost of $7.4 million and $6.1 million, respectively, was recognized related to outstanding stock options. During the six-month periods ended June 30, 2014 and 2013, compensation cost of $14.2 million and $12.8 million, respectively was recognized related to outstanding stock options. In addition, during the three-month periods ended June 30, 2014 and 2013, compensation cost of approximately $358,000 and $307,000, respectively, was recognized related to restricted stock. During the six-month periods ended June 30, 2014 and 2013, compensation cost of approximately $648,000 and $712,000, respectively, was recognized related to restricted stock. As of June 30, 2014 there was $64.8 million of unrecognized compensation cost related to unvested options and restricted stock which is expected to be recognized over the remaining weighted average vesting period of 2.9 years. There were 2,746,500 stock options granted (net of cancellations) during the first six months of 2014 with a weighted-average grant date fair value of $17.13 per share.

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities and aggregated to $14.9 million and $13.5 million during the six-month periods ended June 30, 2014 and 2013, respectively. In accordance with ASC 718, excess income tax benefits related to stock based compensation are classified as cash inflows from financing activities on the Consolidated Statement of Cash Flows. Previously for the six-month period ended June 30, 2013, we included $15.1 million of excess income tax benefits related to stock based compensation as net cash provided by operating activities as included in the change in accrued and deferred income taxes for that period. In our Consolidated Statements of Cash Flows, as included herein, that amount is reflected as cash inflows from financing activities for the 2013 six-month period. We assessed this misclassification and concluded that it was not material to our previously issued quarterly Consolidated Statements of Cash Flows. During the first six months of 2014, we generated $28.5 million of excess income tax benefits related to stock based compensation which are reflected as cash inflows from financing activities in our Consolidated Statements of Cash Flows.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References+ Details

Dispositions and acquisitions

6 Months Ended

Jun. 30, 2014

Dispositions and acquisitions

(8) Dispositions and acquisitions

Six-month periods ended June 30, 2014 and 2013:

Acquisitions:

During the first six months of 2014, we spent $71 million to: (i) acquire and fund the required capital reserves related to a commercial health insurer headquartered in Reno, Nevada; (ii) acquire the Psychiatric Institute of Washington (“PIW”), a 124-bed behavioral health care facility and outpatient treatment center located in Washington, D.C., and; (iii) to acquire the operations of Palo Verde Behavioral Health, a 48-bed behavioral health facility in Tucson, Arizona. As part of the acquisition of PIW, we also acquired the Arbor Group, L.L.C., which operates three management contracts covering 66 beds in the Washington, D.C. and Maryland market. The aggregate net purchase price of these acquisitions was allocated to the assets and liabilities based on their preliminary estimated fair values.

During the first six months of 2013, we spent approximately $1 million in connection with the acquisition of real property located in Pennsylvania.

Divestitures:

During the first six months of 2014, we received approximately $11 million of cash proceeds for the divestiture of a non-operating investment (sold during the first quarter of 2014). This transaction resulted in a pre-tax gain of approximately $10 million which is included in our consolidated results of operations during the six-month period ended June 30, 2014.

During the first six months of 2013, we received aggregate cash proceeds of approximately $34 million for the divestiture of Peak Behavioral Health Services (“Peak”), a 104-bed behavioral health care facility located in Santa Teresa, New Mexico, and certain real property, including three previously closed behavioral health care facilities. In connection with the receipt of antitrust clearance from the Federal Trade Commission in connection with our acquisition of Ascend Health Corporation in October of 2012, we agreed to divest Peak Behavioral Health Services. The pre-tax net gain on these divestitures did not have a material impact on our consolidated results of operations during the three or six-month periods ended June 30, 2013.

Income Taxes

6 Months Ended

Jun. 30, 2014

Income Taxes

(10) Income Taxes

As of January 1, 2014, our unrecognized tax benefits were approximately $3 million. The amount, if recognized, that would affect the effective tax rate is approximately $2 million. During the quarter ended June 30, 2014, changes to the estimated liabilities for uncertain tax positions (including accrued interest) relating to tax positions taken during prior and current periods did not have a material impact on our financial statements.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of June 30, 2014, we have less than $1 million of accrued interest and penalties. The U.S. federal statute of limitations remains open for the 2010 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging from 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months. It is reasonably possible that the amount of uncertain tax benefits will change during the next 12 months, however, it is anticipated that any such change, if it were to occur, would not have a material impact on our result of operations.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service (“IRS”) through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References+ Details

Supplemental Condensed Consolidating Financial Information

6 Months Ended

Jun. 30, 2014

Supplemental Condensed Consolidating Financial Information

(11) Supplemental Condensed Consolidating Financial Information

Certain of our senior notes are guaranteed by a group of subsidiaries (the “Guarantors”). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company’s and Guarantors’ investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non guarantors.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,520,223		$	683,074		$	(7,521	)	$	2,195,776
Less: Provision for doubtful accounts		0			121,531			54,424			0			175,955

Net revenues		0			1,398,692			628,650			(7,521	)		2,019,821

Operating charges:
Salaries, wages and benefits		0			688,041			273,879			0			961,920
Other operating expenses		0			283,869			151,927			(7,076	)		428,720
Supplies expense		0			136,754			87,020			0			223,774
Depreciation and amortization		0			64,622			26,069			0			90,691
Lease and rental expense		0			14,444			9,459			(445	)		23,458
Electronic health records incentive income		0			(1,704	)		(470	)		0			(2,174	)

		0			1,186,026			547,884			(7,521	)		1,726,389

Income from operations		0			212,666			80,766			0			293,432
Interest expense		33,589			1,147			351			0			35,087
Interest (income) expense, affiliate		0			22,112			(22,112	)		0			0
Equity in net income of consolidated affiliates		(172,404	)		(49,911	)		0			222,315			0

Income before income taxes		138,815			239,318			102,527			(222,315	)		258,345
Provision for income taxes		(12,856	)		84,448			20,139			0			91,731

Net income		151,671			154,870			82,388			(222,315	)		166,614
Less: Income attributable to noncontrolling interests		0			0			14,943			0			14,943

Net income attributable to UHS	$	151,671		$	154,870		$	67,445		$	(222,315	)	$	151,671

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,984,143		$	1,354,661		$	(14,678	)	$	4,324,126
Less: Provision for doubtful accounts		0			257,517			126,622			0			384,139

Net revenues		0			2,726,626			1,228,039			(14,678	)		3,939,987

Operating charges:
Salaries, wages and benefits		0			1,357,294			539,991			0			1,897,285
Other operating expenses		0			524,045			300,452			(14,017	)		810,480
Supplies expense		0			268,229			171,343			0			439,572
Depreciation and amortization		0			132,336			51,714			0			184,050
Lease and rental expense		0			28,793			18,664			(661	)		46,796
Electronic health records incentive income		0			(2,134	)		(470	)		0			(2,604	)

		0			2,308,563			1,081,694			(14,678	)		3,375,579

Income from operations		0			418,063			146,345			0			564,408
Interest expense		67,162			1,971			1,147			0			70,280
Interest (income) expense, affiliate		0			44,224			(44,224	)		0			0
Equity in net income of consolidated affiliates		(331,205	)		(92,863	)		0			424,068			0

Income before income taxes		264,043			464,731			189,422			(424,068	)		494,128
Provision for income taxes		(25,706	)		163,201			38,167			0			175,662

Net income		289,749			301,530			151,255			(424,068	)		318,466
Less: Income attributable to noncontrolling interests		0			0			28,717			0			28,717

Net income attributable to UHS	$	289,749		$	301,530		$	122,538		$	(424,068	)	$	289,749

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,416,011		$	672,949		$	(7,298	)	$	2,081,662
Less: Provision for doubtful accounts		0			150,294			96,393			0			246,687

Net revenues		0			1,265,717			576,556			(7,298	)		1,834,975

Operating charges:
Salaries, wages and benefits		0			639,421			257,913			0			897,334
Other operating expenses		0			193,388			139,063			(6,889	)		325,562
Supplies expense		0			123,894			78,450			0			202,344
Depreciation and amortization		0			57,597			24,085			0			81,682
Lease and rental expense		0			15,536			8,955			(409	)		24,082
Electronic health records incentive income		0			(452	)		369			0			(83	)

		0			1,029,384			508,835			(7,298	)		1,530,921

Income from operations		0			236,333			67,721			0			304,054
Interest expense		36,772			846			618			0			38,236
Interest (income) expense, affiliate		0			24,391			(24,391	)		0			0
Equity in net income of consolidated affiliates		(174,539	)		(38,497	)		0			213,036			0

Income before income taxes		137,767			249,593			91,494			(213,036	)		265,818
Provision for income taxes		(14,074	)		93,570			18,519			0			98,015

Net income		151,841			156,023			72,975			(213,036	)		167,803
Less: Income attributable to noncontrolling interests		0			0			15,962			0			15,962

Net income attributable to UHS	$	151,841		$	156,023		$	57,013		$	(213,036	)	$	151,841

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,837,863		$	1,336,155		$	(14,008	)	$	4,160,010
Less: Provision for doubtful accounts		0			300,062			193,341			0			493,403

Net revenues		0			2,537,801			1,142,814			(14,008	)		3,666,607

Operating charges:
Salaries, wages and benefits		0			1,285,015			514,615			0			1,799,630
Other operating expenses		0			437,807			282,266			(13,504	)		706,569
Supplies expense		0			252,604			154,382			0			406,986
Depreciation and amortization		0			113,376			48,118			0			161,494
Lease and rental expense		0			31,211			18,040			(504	)		48,747
Electronic health records incentive income		0			(3,568	)		(1,227	)		0			(4,795	)

		0			2,116,445			1,016,194			(14,008	)		3,118,631

Income from operations		0			421,356			126,620			0			547,976
Interest expense		74,718			1,700			1,756			0			78,174
Interest (income) expense, affiliate		0			48,782			(48,782	)		0			0
Equity in net income of consolidated affiliates		(317,745	)		(70,278	)		0			388,023			0

Income before income taxes		243,027			441,152			173,646			(388,023	)		469,802
Provision for income taxes		(28,598	)		158,893			41,769			0			172,064

Net income		271,625			282,259			131,877			(388,023	)		297,738
Less: Income attributable to noncontrolling interests		0			0			26,113			0			26,113

Net income attributable to UHS	$	271,625		$	282,259		$	105,764		$	(388,023	)	$	271,625

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	151,671		$	154,870	$	82,388	$	(222,315	)	$	166,614
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		4,465			0		0		0			4,465
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		4,381			0		0		0			4,381
Income tax expense related to items of other comprehensive income		1,620			0		0		0			1,620

Total other comprehensive income, net of tax		2,761			0		0		0			2,761

Comprehensive income		154,432			154,870		82,388		(222,315	)		169,375
Less: Comprehensive income attributable to noncontrolling interests		0			0		14,943		0			14,943

Comprehensive income attributable to UHS	$	154,432		$	154,870	$	67,445	$	(222,315	)	$	154,432

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	289,749		$	301,530	$	151,255	$	(424,068	)	$	318,466
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		8,210			0		0		0			8,210
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		8,042			0		0		0			8,042
Income tax expense related to items of other comprehensive income		2,974			0		0		0			2,974

Total other comprehensive income, net of tax		5,068			0		0		0			5,068

Comprehensive income		294,817			301,530		151,255		(424,068	)		323,534
Less: Comprehensive income attributable to noncontrolling interests		0			0		28,717		0			28,717

Comprehensive income attributable to UHS	$	294,817		$	301,530	$	122,538	$	(424,068	)	$	294,817

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	151,841		$	156,023	$	72,975	$	(213,036	)	$	167,803
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		5,282			0		0		0			5,282
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		5,198			0		0		0			5,198
Income tax expense related to items of other comprehensive income		1,960			0		0		0			1,960

Total other comprehensive income, net of tax		3,238			0		0		0			3,238

Comprehensive income		155,079			156,023		72,975		(213,036	)		171,041
Less: Comprehensive income attributable to noncontrolling interests		0			0		15,962		0			15,962

Comprehensive income attributable to UHS	$	155,079		$	156,023	$	57,013	$	(213,036	)	$	155,079

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	271,625		$	282,259	$	131,877	$	(388,023	)	$	297,738
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		9,817			0		0		0			9,817
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		9,649			0		0		0			9,649
Income tax expense related to items of other comprehensive income		3,638			0		0		0			3,638

Total other comprehensive income, net of tax		6,011			0		0		0			6,011

Comprehensive income		277,636			282,259		131,877		(388,023	)		303,749
Less: Comprehensive income attributable to noncontrolling interests		0			0		26,113		0			26,113

Comprehensive income attributable to UHS	$	277,636		$	282,259	$	105,764	$	(388,023	)	$	277,636

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF JUNE 30, 2014

(amounts in thousands)


												Total
						Non			Consolidating			Consolidated
	Parent		Guarantors			Guarantors			Adjustments			Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	4,530		$	10,202		$	0		$	14,732
Accounts receivable, net		0		825,120			360,892			0			1,186,012
Supplies		0		65,008			39,272			0			104,280
Deferred income taxes		63,667		43,692			0			0			107,359
Other current assets		0		103,085			14,413			0			117,498

Total current assets		63,667		1,041,435			424,779			0			1,529,881

Investments in subsidiaries		6,709,704		1,569,774			0			(8,279,478	)		0
Intercompany receivable		51,457		0			505,656			(557,113	)		0
Intercompany note receivable		0		0			1,104,881			(1,104,881	)		0
Property and equipment		0		4,256,178			1,644,985			0			5,901,163
Less: accumulated depreciation		0		(1,579,351	)		(807,133	)		0			(2,386,484	)

		0		2,676,827			837,852			0			3,514,679

Other assets:
Goodwill		0		2,589,121			500,051			0			3,089,172
Deferred charges		40,985		5,469			2,522			0			48,976
Other		7,392		294,755			63,217			0			365,364

	$	6,873,205	$	8,177,381		$	3,438,958		$	(9,941,472	)	$	8,548,072

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	75,803	$	1,052		$	831		$	0		$	77,686
Accounts payable and accrued liabilities		25,038		901,868			111,281			0			1,038,187
Federal and state taxes		0		0			0			0			0

Total current liabilities		100,841		902,920			112,112			0			1,115,873

Intercompany payable		0		557,113			0			(557,113	)		0
Other noncurrent liabilities		2,311		196,428			77,723			0			276,462
Long-term debt		3,024,627		20,970			24,714			0			3,070,311
Intercompany note payable		0		1,104,881			0			(1,104,881	)		0
Deferred income taxes		199,292		55,281			0			0			254,573
Redeemable noncontrolling interests		0		0			231,545			0			231,545
UHS common stockholders’ equity		3,546,134		5,339,788			2,939,690			(8,279,478	)		3,546,134
Noncontrolling interest		0		0			53,174			0			53,174

Total equity		3,546,134		5,339,788			2,992,864			(8,279,478	)		3,599,308

	$	6,873,205	$	8,177,381		$	3,438,958		$	(9,941,472	)	$	8,548,072

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2013

(amounts in thousands)


												Total
						Non			Consolidating			Consolidated
	Parent		Guarantors			Guarantors			Adjustments			Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,990		$	9,248		$	0		$	17,238
Accounts receivable, net		0		799,898			317,063			0			1,116,961
Supplies		0		63,562			38,219			0			101,781
Deferred income taxes		76,719		43,184			0			0			119,903
Other current assets		0		63,786			12,660			0			76,446

Total current assets		76,719		978,420			377,190			0			1,432,329

Investments in subsidiaries		6,378,499		1,476,911			0			(7,855,410	)		0
Intercompany receivable		226,592		0			531,411			(758,003	)		0
Intercompany note receivable		0		0			982,568			(982,568	)		0
Property and equipment		0		4,093,914			1,597,988			0			5,691,902
Less: accumulated depreciation		0		(1,478,758	)		(770,975	)		0			(2,249,733	)

		0		2,615,156			827,013			0			3,442,169

Other assets:
Goodwill		0		2,552,190			496,826			0			3,049,016
Deferred charges		49,866		5,577			2,438			0			57,881
Other		8,411		251,365			70,552			0			330,328

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	97,403		916			993			0		$	99,312
Accounts payable and accrued liabilities		28,099		837,354			87,996			0			953,449
Federal and state taxes		4,963		2,164			0			0			7,127

Total current liabilities		130,465		840,434			88,989			0			1,059,888

Intercompany payable		0		758,003			0			(758,003	)		0
Other noncurrent liabilities		7,591		199,104			77,894			0			284,589
Long-term debt		3,168,819		5,337			35,606			0			3,209,762
Intercompany note payable		0		982,568			0			(982,568	)		0
Deferred income taxes		183,233		55,915			0			0			239,148
Redeemable noncontrolling interests		0		0			218,107			0			218,107
UHS common stockholders’ equity		3,249,979		5,038,258			2,817,152			(7,855,410	)		3,249,979
Noncontrolling interest		0		0			50,250			0			50,250

Total equity		3,249,979		5,038,258			2,867,402			(7,855,410	)		3,300,229

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


												Total
							Non			Consolidating		Consolidated
	Parent			Guarantors			Guarantors			Adjustments		Amounts
Net cash provided by operating activities	$	6,497			256,770			195,149		$	0	$	458,416

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(116,688	)		(70,098	)		0		(186,786	)
Proceeds received from sale of assets and businesses		0			11,450			0			0		11,450
Cash paid/reserved related to acquisition of property and businesses		0			(67,699	)		(3,301	)		0		(71,000	)
Costs incurred for purchase and implementation of electronic health records application		0			(8,399	)		0			0		(8,399	)

Net cash used in investing activities		0			(181,336	)		(73,399	)		0		(254,735	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(167,755	)		(317	)		(11,054	)		0		(179,126	)
Repurchase of common shares		(35,773	)		0			0			0		(35,773	)
Dividends paid		(9,884	)		0			0			0		(9,884	)
Issuance of common stock		3,287			0			0			0		3,287
Excess income tax benefits related to stock-based compensation		28,493			0			0			0		28,493
Profit distributions to noncontrolling interests		0			0			(13,184	)		0		(13,184	)
Changes in intercompany balances with affiliates, net		175,135			(78,577	)		(96,558	)		0		0

Net cash (used in) provided by financing activities		(6,497	)		(78,894	)		(120,796	)		0		(206,187	)

(Decrease) increase in cash and cash equivalents		0			(3,460	)		954			0		(2,506	)
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238

Cash and cash equivalents, end of period	$	0		$	4,530		$	10,202		$	0	$	14,732

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


												Total
							Non			Consolidating		Consolidated
	Parent			Guarantors			Guarantors			Adjustments		Amounts
Net cash provided by operating activities	$	929		$	242,016			147,972		$	0	$	390,917

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(133,607	)		(42,337	)		0		(175,944	)
Proceeds received from sale of assets and businesses		0			7,552			26,456			0		34,008
Cash paid/reserved related to acquisition of property and businesses		0			(1,320	)		0			0		(1,320	)
Costs incurred for purchase and implementation of electronic health records application		0			(33,396	)		0			0		(33,396	)

Net cash used in investing activities		0			(160,771	)		(15,881	)		0		(176,652	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(189,188	)		(526	)		(6,382	)		0		(196,096	)
Additional borrowings		11,000			0			0			0		11,000
Repurchase of common shares		(21,373	)		0			0			0		(21,373	)
Dividends paid		(9,795	)		0			0			0		(9,795	)
Issuance of common stock		2,735			0			0			0		2,735
Excess income tax benefits related to stock-based compensation		15,085			0			0			0		15,085
Profit distributions to noncontrolling interests		0			0			(26,734	)		0		(26,734	)
Changes in intercompany balances with affiliates, net		190,607			(89,098	)		(101,509	)		0		0

Net cash used in financing activities		(929	)		(89,624	)		(134,625	)		0		(225,178	)

Decrease in cash and cash equivalents		0			(8,379	)		(2,534	)		0		(10,913	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471

Cash and cash equivalents, end of period	$	0		$	3,570		$	8,988		$	0	$	12,558

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References+ Details

Recent Accounting Standards

6 Months Ended

Jun. 30, 2014

Recent Accounting Standards

(12) Recent Accounting Standards

In April 2014, the Financial Accounting Standards Board (“FASB”) updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results. The updated guidance is applicable to us effective January 1, 2015 with early adoption permitted. We do not expect the adoption of this update to have a material impact on our consolidated financial statements.

In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers”, which provides guidance for revenue recognition. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosures. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016. We are currently in the process of evaluating the impact of adoption of this ASU on our consolidated financial statements.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 01

-Paragraph b

-Subparagraph 6

-Article 10

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22583-107794

+ Details

Relationship with Universal Health Realty Income Trust and Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2014

Remaining Renewal Options and Terms for Each of Four Hospital Facilities Leased from Trust

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2014

Segment Reporting


	Three months ended June 30, 2014
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
				(Amounts in thousands)
Gross inpatient revenues	$	3,724,309		$	1,686,512			—		$	5,410,821
Gross outpatient revenues	$	2,068,076		$	204,480		$	8,335		$	2,280,891
Total net revenues	$	1,024,011		$	992,348		$	3,462		$	2,019,821
Income/(loss) before allocation of corporate overhead and income taxes	$	118,345		$	243,540		($	103,540	)	$	258,345
Allocation of corporate overhead	($	44,693	)	($	23,136	)	$	67,829			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	73,652		$	220,404		($	35,711	)	$	258,345
Total assets as of 6/30/14	$	3,319,048		$	4,995,534		$	233,490		$	8,548,072


	Six months ended June 30, 2014
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	7,600,673		$	3,295,411			—		$	10,896,084
Gross outpatient revenues	$	4,025,567		$	388,595		$	16,849		$	4,431,011
Total net revenues	$	1,995,400		$	1,937,805		$	6,782		$	3,939,987
Income/(loss) before allocation of corporate overhead and income taxes	$	229,994		$	464,688		($	200,554	)	$	494,128
Allocation of corporate overhead	($	89,390	)	($	49,305	)	$	138,695			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	140,604		$	415,383		($	61,859	)	$	494,128
Total assets as of 6/30/14	$	3,319,048		$	4,995,534		$	233,490		$	8,548,072

	Three months ended June 30, 2013
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	3,321,154		$	1,598,383			—		$	4,919,537
Gross outpatient revenues	$	1,708,200		$	193,703		$	10,625		$	1,912,528
Total net revenues	$	894,639		$	929,470		$	10,866		$	1,834,975
Income/(loss) before allocation of corporate overhead and income taxes	$	118,390		$	240,556		($	93,128	)	$	265,818
Allocation of corporate overhead	($	46,109	)	($	22,461	)	$	68,570			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	72,281		$	218,095		($	24,558	)	$	265,818
Total assets as of 6/30/13	$	3,126,223		$	4,919,566		$	271,464		$	8,317,253


	Six months ended June 30, 2013
	Acute Care			Behavioral
	Hospital			Health						Total
	Services			Services			Other			Consolidated
	(Amounts in thousands)
Gross inpatient revenues	$	6,828,424		$	3,174,531			—		$	10,002,955
Gross outpatient revenues	$	3,359,775		$	379,505		$	21,473		$	3,760,753
Total net revenues	$	1,803,373		$	1,839,014		$	24,220		$	3,666,607
Income/(loss) before allocation of corporate overhead and income taxes	$	199,019		$	461,331		($	190,548	)	$	469,802
Allocation of corporate overhead	($	92,221	)	($	44,828	)	$	137,049			0
Income/(loss) after allocation of corporate overhead and before income taxes	$	106,798		$	416,503		($	53,499	)	$	469,802
Total assets as of 6/30/13	$	3,126,223		$	4,919,566		$	271,464		$	8,317,253

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation (Tables)

6 Months Ended

Jun. 30, 2014

Computation of Basic and Diluted Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share for the periods indicated (in thousands, except per share data):


	Three months ended						Six months ended
	June 30,						June 30,
	2014			2013			2014			2013
	(amounts in thousands)
Basic and Diluted:
Net income attributable to UHS	$	151,671		$	151,841		$	289,749		$	271,625
Less: Net income attributable to unvested restricted share grants		(77	)		(88	)		(147	)		(157	)

Net income attributable to UHS – basic and diluted	$	151,594		$	151,753		$	289,602		$	271,468

Weighted average number of common shares—basic		98,872			98,033			98,722			97,872
Net effect of dilutive stock options and grants based on the treasury stock method		1,363			1,178			1,474			1,019

Weighted average number of common shares and equivalents—diluted		100,235			99,211			100,196			98,891

Earnings per basic share attributable to UHS:	$	1.53		$	1.55		$	2.93		$	2.77

Earnings per diluted share attributable to UHS:	$	1.51		$	1.53		$	2.89		$	2.75

Supplemental Condensed Consolidating Financial Information (Tables)

6 Months Ended

Jun. 30, 2014

Condensed Consolidating Statements of Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,520,223		$	683,074		$	(7,521	)	$	2,195,776
Less: Provision for doubtful accounts		0			121,531			54,424			0			175,955

Net revenues		0			1,398,692			628,650			(7,521	)		2,019,821

Operating charges:
Salaries, wages and benefits		0			688,041			273,879			0			961,920
Other operating expenses		0			283,869			151,927			(7,076	)		428,720
Supplies expense		0			136,754			87,020			0			223,774
Depreciation and amortization		0			64,622			26,069			0			90,691
Lease and rental expense		0			14,444			9,459			(445	)		23,458
Electronic health records incentive income		0			(1,704	)		(470	)		0			(2,174	)

		0			1,186,026			547,884			(7,521	)		1,726,389

Income from operations		0			212,666			80,766			0			293,432
Interest expense		33,589			1,147			351			0			35,087
Interest (income) expense, affiliate		0			22,112			(22,112	)		0			0
Equity in net income of consolidated affiliates		(172,404	)		(49,911	)		0			222,315			0

Income before income taxes		138,815			239,318			102,527			(222,315	)		258,345
Provision for income taxes		(12,856	)		84,448			20,139			0			91,731

Net income		151,671			154,870			82,388			(222,315	)		166,614
Less: Income attributable to noncontrolling interests		0			0			14,943			0			14,943

Net income attributable to UHS	$	151,671		$	154,870		$	67,445		$	(222,315	)	$	151,671

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,984,143		$	1,354,661		$	(14,678	)	$	4,324,126
Less: Provision for doubtful accounts		0			257,517			126,622			0			384,139

Net revenues		0			2,726,626			1,228,039			(14,678	)		3,939,987

Operating charges:
Salaries, wages and benefits		0			1,357,294			539,991			0			1,897,285
Other operating expenses		0			524,045			300,452			(14,017	)		810,480
Supplies expense		0			268,229			171,343			0			439,572
Depreciation and amortization		0			132,336			51,714			0			184,050
Lease and rental expense		0			28,793			18,664			(661	)		46,796
Electronic health records incentive income		0			(2,134	)		(470	)		0			(2,604	)

		0			2,308,563			1,081,694			(14,678	)		3,375,579

Income from operations		0			418,063			146,345			0			564,408
Interest expense		67,162			1,971			1,147			0			70,280
Interest (income) expense, affiliate		0			44,224			(44,224	)		0			0
Equity in net income of consolidated affiliates		(331,205	)		(92,863	)		0			424,068			0

Income before income taxes		264,043			464,731			189,422			(424,068	)		494,128
Provision for income taxes		(25,706	)		163,201			38,167			0			175,662

Net income		289,749			301,530			151,255			(424,068	)		318,466
Less: Income attributable to noncontrolling interests		0			0			28,717			0			28,717

Net income attributable to UHS	$	289,749		$	301,530		$	122,538		$	(424,068	)	$	289,749

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	1,416,011		$	672,949		$	(7,298	)	$	2,081,662
Less: Provision for doubtful accounts		0			150,294			96,393			0			246,687

Net revenues		0			1,265,717			576,556			(7,298	)		1,834,975

Operating charges:
Salaries, wages and benefits		0			639,421			257,913			0			897,334
Other operating expenses		0			193,388			139,063			(6,889	)		325,562
Supplies expense		0			123,894			78,450			0			202,344
Depreciation and amortization		0			57,597			24,085			0			81,682
Lease and rental expense		0			15,536			8,955			(409	)		24,082
Electronic health records incentive income		0			(452	)		369			0			(83	)

		0			1,029,384			508,835			(7,298	)		1,530,921

Income from operations		0			236,333			67,721			0			304,054
Interest expense		36,772			846			618			0			38,236
Interest (income) expense, affiliate		0			24,391			(24,391	)		0			0
Equity in net income of consolidated affiliates		(174,539	)		(38,497	)		0			213,036			0

Income before income taxes		137,767			249,593			91,494			(213,036	)		265,818
Provision for income taxes		(14,074	)		93,570			18,519			0			98,015

Net income		151,841			156,023			72,975			(213,036	)		167,803
Less: Income attributable to noncontrolling interests		0			0			15,962			0			15,962

Net income attributable to UHS	$	151,841		$	156,023		$	57,013		$	(213,036	)	$	151,841

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


													Total
							Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Net revenues before provision for doubtful accounts	$	0		$	2,837,863		$	1,336,155		$	(14,008	)	$	4,160,010
Less: Provision for doubtful accounts		0			300,062			193,341			0			493,403

Net revenues		0			2,537,801			1,142,814			(14,008	)		3,666,607

Operating charges:
Salaries, wages and benefits		0			1,285,015			514,615			0			1,799,630
Other operating expenses		0			437,807			282,266			(13,504	)		706,569
Supplies expense		0			252,604			154,382			0			406,986
Depreciation and amortization		0			113,376			48,118			0			161,494
Lease and rental expense		0			31,211			18,040			(504	)		48,747
Electronic health records incentive income		0			(3,568	)		(1,227	)		0			(4,795	)

		0			2,116,445			1,016,194			(14,008	)		3,118,631

Income from operations		0			421,356			126,620			0			547,976
Interest expense		74,718			1,700			1,756			0			78,174
Interest (income) expense, affiliate		0			48,782			(48,782	)		0			0
Equity in net income of consolidated affiliates		(317,745	)		(70,278	)		0			388,023			0

Income before income taxes		243,027			441,152			173,646			(388,023	)		469,802
Provision for income taxes		(28,598	)		158,893			41,769			0			172,064

Net income		271,625			282,259			131,877			(388,023	)		297,738
Less: Income attributable to noncontrolling interests		0			0			26,113			0			26,113

Net income attributable to UHS	$	271,625		$	282,259		$	105,764		$	(388,023	)	$	271,625

Condensed Consolidating Statements of Comprehensive Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	151,671		$	154,870	$	82,388	$	(222,315	)	$	166,614
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		4,465			0		0		0			4,465
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		4,381			0		0		0			4,381
Income tax expense related to items of other comprehensive income		1,620			0		0		0			1,620

Total other comprehensive income, net of tax		2,761			0		0		0			2,761

Comprehensive income		154,432			154,870		82,388		(222,315	)		169,375
Less: Comprehensive income attributable to noncontrolling interests		0			0		14,943		0			14,943

Comprehensive income attributable to UHS	$	154,432		$	154,870	$	67,445	$	(222,315	)	$	154,432

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	289,749		$	301,530	$	151,255	$	(424,068	)	$	318,466
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		8,210			0		0		0			8,210
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		8,042			0		0		0			8,042
Income tax expense related to items of other comprehensive income		2,974			0		0		0			2,974

Total other comprehensive income, net of tax		5,068			0		0		0			5,068

Comprehensive income		294,817			301,530		151,255		(424,068	)		323,534
Less: Comprehensive income attributable to noncontrolling interests		0			0		28,717		0			28,717

Comprehensive income attributable to UHS	$	294,817		$	301,530	$	122,538	$	(424,068	)	$	294,817

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	151,841		$	156,023	$	72,975	$	(213,036	)	$	167,803
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		5,282			0		0		0			5,282
Amortization of terminated hedge		(84	)		0		0		0			(84	)

Other comprehensive income before tax		5,198			0		0		0			5,198
Income tax expense related to items of other comprehensive income		1,960			0		0		0			1,960

Total other comprehensive income, net of tax		3,238			0		0		0			3,238

Comprehensive income		155,079			156,023		72,975		(213,036	)		171,041
Less: Comprehensive income attributable to noncontrolling interests		0			0		15,962		0			15,962

Comprehensive income attributable to UHS	$	155,079		$	156,023	$	57,013	$	(213,036	)	$	155,079

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


											Total
						Non		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Net income	$	271,625		$	282,259	$	131,877	$	(388,023	)	$	297,738
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		9,817			0		0		0			9,817
Amortization of terminated hedge		(168	)		0		0		0			(168	)

Other comprehensive income before tax		9,649			0		0		0			9,649
Income tax expense related to items of other comprehensive income		3,638			0		0		0			3,638

Total other comprehensive income, net of tax		6,011			0		0		0			6,011

Comprehensive income		277,636			282,259		131,877		(388,023	)		303,749
Less: Comprehensive income attributable to noncontrolling interests		0			0		26,113		0			26,113

Comprehensive income attributable to UHS	$	277,636		$	282,259	$	105,764	$	(388,023	)	$	277,636

Condensed Consolidating Balance Sheet

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF JUNE 30, 2014

(amounts in thousands)


												Total
						Non			Consolidating			Consolidated
	Parent		Guarantors			Guarantors			Adjustments			Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	4,530		$	10,202		$	0		$	14,732
Accounts receivable, net		0		825,120			360,892			0			1,186,012
Supplies		0		65,008			39,272			0			104,280
Deferred income taxes		63,667		43,692			0			0			107,359
Other current assets		0		103,085			14,413			0			117,498

Total current assets		63,667		1,041,435			424,779			0			1,529,881

Investments in subsidiaries		6,709,704		1,569,774			0			(8,279,478	)		0
Intercompany receivable		51,457		0			505,656			(557,113	)		0
Intercompany note receivable		0		0			1,104,881			(1,104,881	)		0
Property and equipment		0		4,256,178			1,644,985			0			5,901,163
Less: accumulated depreciation		0		(1,579,351	)		(807,133	)		0			(2,386,484	)

		0		2,676,827			837,852			0			3,514,679

Other assets:
Goodwill		0		2,589,121			500,051			0			3,089,172
Deferred charges		40,985		5,469			2,522			0			48,976
Other		7,392		294,755			63,217			0			365,364

	$	6,873,205	$	8,177,381		$	3,438,958		$	(9,941,472	)	$	8,548,072

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	75,803	$	1,052		$	831		$	0		$	77,686
Accounts payable and accrued liabilities		25,038		901,868			111,281			0			1,038,187
Federal and state taxes		0		0			0			0			0

Total current liabilities		100,841		902,920			112,112			0			1,115,873

Intercompany payable		0		557,113			0			(557,113	)		0
Other noncurrent liabilities		2,311		196,428			77,723			0			276,462
Long-term debt		3,024,627		20,970			24,714			0			3,070,311
Intercompany note payable		0		1,104,881			0			(1,104,881	)		0
Deferred income taxes		199,292		55,281			0			0			254,573
Redeemable noncontrolling interests		0		0			231,545			0			231,545
UHS common stockholders’ equity		3,546,134		5,339,788			2,939,690			(8,279,478	)		3,546,134
Noncontrolling interest		0		0			53,174			0			53,174

Total equity		3,546,134		5,339,788			2,992,864			(8,279,478	)		3,599,308

	$	6,873,205	$	8,177,381		$	3,438,958		$	(9,941,472	)	$	8,548,072

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2013

(amounts in thousands)


												Total
						Non			Consolidating			Consolidated
	Parent		Guarantors			Guarantors			Adjustments			Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	7,990		$	9,248		$	0		$	17,238
Accounts receivable, net		0		799,898			317,063			0			1,116,961
Supplies		0		63,562			38,219			0			101,781
Deferred income taxes		76,719		43,184			0			0			119,903
Other current assets		0		63,786			12,660			0			76,446

Total current assets		76,719		978,420			377,190			0			1,432,329

Investments in subsidiaries		6,378,499		1,476,911			0			(7,855,410	)		0
Intercompany receivable		226,592		0			531,411			(758,003	)		0
Intercompany note receivable		0		0			982,568			(982,568	)		0
Property and equipment		0		4,093,914			1,597,988			0			5,691,902
Less: accumulated depreciation		0		(1,478,758	)		(770,975	)		0			(2,249,733	)

		0		2,615,156			827,013			0			3,442,169

Other assets:
Goodwill		0		2,552,190			496,826			0			3,049,016
Deferred charges		49,866		5,577			2,438			0			57,881
Other		8,411		251,365			70,552			0			330,328

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	97,403		916			993			0		$	99,312
Accounts payable and accrued liabilities		28,099		837,354			87,996			0			953,449
Federal and state taxes		4,963		2,164			0			0			7,127

Total current liabilities		130,465		840,434			88,989			0			1,059,888

Intercompany payable		0		758,003			0			(758,003	)		0
Other noncurrent liabilities		7,591		199,104			77,894			0			284,589
Long-term debt		3,168,819		5,337			35,606			0			3,209,762
Intercompany note payable		0		982,568			0			(982,568	)		0
Deferred income taxes		183,233		55,915			0			0			239,148
Redeemable noncontrolling interests		0		0			218,107			0			218,107
UHS common stockholders’ equity		3,249,979		5,038,258			2,817,152			(7,855,410	)		3,249,979
Noncontrolling interest		0		0			50,250			0			50,250

Total equity		3,249,979		5,038,258			2,867,402			(7,855,410	)		3,300,229

	$	6,740,087	$	7,879,619		$	3,287,998		$	(9,595,981	)	$	8,311,723

Condensed Consolidating Statements of Cash Flows

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2014

(amounts in thousands)


												Total
							Non			Consolidating		Consolidated
	Parent			Guarantors			Guarantors			Adjustments		Amounts
Net cash provided by operating activities	$	6,497			256,770			195,149		$	0	$	458,416

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(116,688	)		(70,098	)		0		(186,786	)
Proceeds received from sale of assets and businesses		0			11,450			0			0		11,450
Cash paid/reserved related to acquisition of property and businesses		0			(67,699	)		(3,301	)		0		(71,000	)
Costs incurred for purchase and implementation of electronic health records application		0			(8,399	)		0			0		(8,399	)

Net cash used in investing activities		0			(181,336	)		(73,399	)		0		(254,735	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(167,755	)		(317	)		(11,054	)		0		(179,126	)
Repurchase of common shares		(35,773	)		0			0			0		(35,773	)
Dividends paid		(9,884	)		0			0			0		(9,884	)
Issuance of common stock		3,287			0			0			0		3,287
Excess income tax benefits related to stock-based compensation		28,493			0			0			0		28,493
Profit distributions to noncontrolling interests		0			0			(13,184	)		0		(13,184	)
Changes in intercompany balances with affiliates, net		175,135			(78,577	)		(96,558	)		0		0

Net cash (used in) provided by financing activities		(6,497	)		(78,894	)		(120,796	)		0		(206,187	)

(Decrease) increase in cash and cash equivalents		0			(3,460	)		954			0		(2,506	)
Cash and cash equivalents, beginning of period		0			7,990			9,248			0		17,238

Cash and cash equivalents, end of period	$	0		$	4,530		$	10,202		$	0	$	14,732

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(amounts in thousands)


												Total
							Non			Consolidating		Consolidated
	Parent			Guarantors			Guarantors			Adjustments		Amounts
Net cash provided by operating activities	$	929		$	242,016			147,972		$	0	$	390,917

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(133,607	)		(42,337	)		0		(175,944	)
Proceeds received from sale of assets and businesses		0			7,552			26,456			0		34,008
Cash paid/reserved related to acquisition of property and businesses		0			(1,320	)		0			0		(1,320	)
Costs incurred for purchase and implementation of electronic health records application		0			(33,396	)		0			0		(33,396	)

Net cash used in investing activities		0			(160,771	)		(15,881	)		0		(176,652	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(189,188	)		(526	)		(6,382	)		0		(196,096	)
Additional borrowings		11,000			0			0			0		11,000
Repurchase of common shares		(21,373	)		0			0			0		(21,373	)
Dividends paid		(9,795	)		0			0			0		(9,795	)
Issuance of common stock		2,735			0			0			0		2,735
Excess income tax benefits related to stock-based compensation		15,085			0			0			0		15,085
Profit distributions to noncontrolling interests		0			0			(26,734	)		0		(26,734	)
Changes in intercompany balances with affiliates, net		190,607			(89,098	)		(101,509	)		0		0

Net cash used in financing activities		(929	)		(89,624	)		(134,625	)		0		(225,178	)

Decrease in cash and cash equivalents		0			(8,379	)		(2,534	)		0		(10,913	)
Cash and cash equivalents, beginning of period		0			11,949			11,522			0		23,471

Cash and cash equivalents, end of period	$	0		$	3,570		$	8,988		$	0	$	12,558

Relationship with Universal Health Realty Income Trust and Related Party Transactions - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies			$ 25,000,000
Chief Executive Officer \| Minimum
Related Party Transaction [Line Items]
Estimated death benefit proceeds			33,000,000
Chief Executive Officer \| Trust Owned by Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies			8,000,000
Relationship with Universal Health Realty Income Trust
Related Party Transaction [Line Items]
Trust outstanding shares held, percentage	6.10%		6.10%
Advisory fee earned	600,000	600,000	1,200,000	1,200,000
Pre-tax share of income from the Trust	100,000	200,000	400,000	500,000
Carrying value of investment in Trust	8,000,000		8,000,000		8,000,000
Market value of investment in Trust	34,000,000		34,000,000		32,000,000
Rent expense under operating leases	$ 4,000,000	$ 4,000,000	$ 8,000,000	$ 8,000,000
Non-controlling ownership interests by subsidiaries	100.00%		100.00%

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Detail) (USD $)
In Thousands, unless otherwise specified

6 Months Ended

Jun. 30, 2014

McAllen Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

$ 5,485

2016-12

15 years

^[1]

Wellington Regional Medical Center

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

3,030

2016-12

15 years

^[2]

Southwest Healthcare System, Inland Valley Campus

Property Subject to or Available for Operating Lease [Line Items]

Acute Care

2,648

2016-12

15 years

^[2]

The Bridgeway

Property Subject to or Available for Operating Lease [Line Items]

Behavioral Health

$ 930

2014-12

10 years

^[3]

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
[3]	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Remaining Renewal Options and Terms for Hospital Facilities Leased from Trust (Parenthetical) (Detail)	6 Months Ended
	Jun. 30, 2014 RenewalOptions
McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	3
Renewal options term at existing lease rates	5 years
Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
The Bridgeway
Property Subject to or Available for Operating Lease [Line Items]
Number of renewal options at fair market lease rates	2
Renewal options term at fair market lease rates	5 years
Maximum \| McAllen Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2031
Maximum \| Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| The Bridgeway
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2024
Minimum \| Wellington Regional Medical Center
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| Southwest Healthcare System, Inland Valley Campus
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| The Bridgeway
Property Subject to or Available for Operating Lease [Line Items]
Renewal options at fair market value lease rates expiration year	2015

Other Noncurrent Liabilities and Redeemable/Noncontrolling Interests - Additional Information (Detail) (USD $)			6 Months Ended
	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014 Acute Care Hospital Services Las Vegas, Nevada Facility	Jun. 30, 2014 Acute Care Hospital Services Washington, District of Columbia	Jun. 30, 2014 Acute Care Hospital Services Laredo, Texas	Jun. 30, 2014 Behavioral Health Services Philadelphia, Pennsylvania
Noncontrolling Interest [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners			28.00%	20.00%	11.00%	20.00%
Number of facilities			5
Redeemable noncontrolling interests	$ 232,000,000	$ 218,000,000
Noncontrolling interest balance	$ 53,174,000	$ 50,250,000

- Definition

As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.

+ References+ Details

Long-term debt and cash flow hedges - Additional Information (Detail) (USD $)	3 Months Ended	6 Months Ended		12 Months Ended							3 Months Ended		6 Months Ended		3 Months Ended		0 Months Ended		0 Months Ended					3 Months Ended			12 Months Ended																										1 Months Ended	6 Months Ended	0 Months Ended		6 Months Ended				0 Months Ended
	Mar. 31, 2011 Derivative	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2010 Derivative	Dec. 31, 2013	Jun. 30, 2014 Revolving Credit Facility	Jun. 30, 2014 Term Loan A	Jun. 30, 2014 Term Loan- A2	Jun. 30, 2014 Term Loan B Facility	Jun. 30, 2014 Previous Credit Facility	Jun. 30, 2014 Term Loan-A and Term Loan A2 facilities	Jun. 30, 2013 Term Loan-A and Term Loan A2 facilities	Jun. 30, 2014 Term Loan-A and Term Loan A2 facilities	Jun. 30, 2013 Term Loan-A and Term Loan A2 facilities	Jun. 30, 2014 Term Loan-A and Term Loan A2 facilities Quarterly installment payments commence in the fourth quarter of 2014 through September, 2016	Jun. 30, 2014 Term Loan-A and Term Loan A2 facilities Quarterly installment payments after September, 2016	Aug. 07, 2014 Subsequent Event Term Loan B Facility	Oct. 31, 2013 Amendment of Credit Facility	Aug. 07, 2014 Amendment of Credit Facility Subsequent Event	Aug. 01, 2014 Amendment of Credit Facility Subsequent Event	Aug. 07, 2014 Amendment of Credit Facility Subsequent Event Revolving Credit Facility	Aug. 07, 2014 Amendment of Credit Facility Subsequent Event Term Loan A	Mar. 31, 2011 One Point Nine One Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Two Point Five Zero Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 One Point Nine Six Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 One Point Three Two Percent Forward Starting Interest Rate Swaps	Dec. 31, 2010 Two Point Three Eight Percent Forward Starting Interest Rate Swaps	Jun. 30, 2014 Interest Rate Swap	Dec. 31, 2013 Interest Rate Swap	Jun. 30, 2014 Short Term on Demand Credit Facility Revolving Credit Facility	Jun. 30, 2014 Letter of Credit Revolving Credit Facility	Mar. 31, 2011 Cash Flow Hedging Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging One Point Nine One Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging Two Point Five Zero Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging One Point Nine Six Percent Forward Starting Interest Rate Swaps	Mar. 31, 2011 Cash Flow Hedging One Point Three Two Percent Forward Starting Interest Rate Swaps	Dec. 31, 2010 Cash Flow Hedging Two Point Three Eight Percent Forward Starting Interest Rate Swaps	Jun. 30, 2014 One Month Eurodollar Rate Plus Index Based Loans Term Loan B Facility	Jun. 30, 2014 One Two Three Six Month Eurodollar Rate Plus Index Based Loans Revolving Credit Facility	Jun. 30, 2014 One Two Three Six Month Eurodollar Rate Plus Index Based Loans Term Loan B Facility	Jun. 30, 2014 ABR-based loans	Jun. 30, 2014 Minimum One Month Eurodollar Rate Plus Index Based Loans Revolving Credit Facility	Jun. 30, 2014 Minimum One Month Eurodollar Rate Plus Index Based Loans Term Loan A	Jun. 30, 2014 Minimum One Month Eurodollar Rate Plus Index Based Loans Term Loan- A2	Jun. 30, 2014 Minimum One Two Three Six Month Eurodollar Rate Plus Index Based Loans Term Loan A	Jun. 30, 2014 Minimum One Two Three Six Month Eurodollar Rate Plus Index Based Loans Term Loan- A2	Jun. 30, 2014 Maximum One Month Eurodollar Rate Plus Index Based Loans Revolving Credit Facility	Jun. 30, 2014 Maximum One Month Eurodollar Rate Plus Index Based Loans Term Loan A	Jun. 30, 2014 Maximum One Month Eurodollar Rate Plus Index Based Loans Term Loan- A2	Jun. 30, 2014 Maximum One Two Three Six Month Eurodollar Rate Plus Index Based Loans Revolving Credit Facility	Jun. 30, 2014 Maximum One Two Three Six Month Eurodollar Rate Plus Index Based Loans Term Loan A	Jun. 30, 2014 Maximum One Two Three Six Month Eurodollar Rate Plus Index Based Loans Term Loan- A2	Sep. 29, 2010 7.00% Senior Unsecured Notes	Jun. 30, 2014 7.00% Senior Unsecured Notes	Jul. 31, 2014 7.00% Senior Unsecured Notes Subsequent Event	Jul. 31, 2014 7.00% Senior Unsecured Notes Subsequent Event	Jun. 30, 2014 Senior Notes 7.125%	Jun. 30, 2008 Senior Notes 7.125%	Jun. 30, 2006 Senior Notes 7.125%	Jun. 30, 2014 Accounts Receivable Securitization Facility	Aug. 01, 2014 Accounts Receivable Securitization Facility Amendment of Credit Facility Subsequent Event	Aug. 07, 2014 Three Point Seven Five Zero Percent Senior Secured Notes Due Two Thousand Nineteen Subsequent Event	Aug. 07, 2014 Four Point Seven Five Zero Percent Senior Secured Notes Due Two Thousand Twenty Two Subsequent Event	Dec. 31, 2013 Accounts Payable and Accrued Liabilities Interest Rate Swap	Dec. 31, 2013 Other Noncurrent Liabilities Interest Rate Swap
Debt Instrument [Line Items]
Line of credit facility, starting date																			Aug. 07, 2014																																										Aug. 01, 2014
Line of credit facility, maturity month																			2019-08
Line of credit facility, borrowing capacity						$ 800,000,000															$ 800,000,000	$ 1,774,000,000									$ 125,000,000
Reduction of long-term debt		179,126,000	196,096,000														550,000,000																																						250,000,000
Line of credit facility, maturity year																	2016
Accounts receivable securitization program credit facility, borrowing capacity																		275,000,000		360,000,000
Line of credit facility, maturity date																																																													Oct. 25, 2016
Senior notes, issued																																																					250,000,000						250,000,000			300,000,000	300,000,000
Senior notes, interest rate																																																					7.00%			7.00%			7.125%			3.75%	4.75%
Debt instrument redemption, date																																																							Jul. 31, 2014
Unsecured notes make-whole redemption price																																																							104.56%
Line of credit facility amount outstanding						0	913,000,000	861,000,000	550,000,000	0																				4,000,000
Rate adjustment to weighted average federal funds rate for credit facility borrowings		0.50%
Rate adjustment to one month Eurodollar rate on credit facility borrowings		1.00%
Consolidated leverage ratio																																						1.25%	1.50%	2.25%		0.50%	0.50%	0.50%	1.50%	1.50%	1.25%	1.25%	1.25%	2.25%	2.25%	2.25%
Current applicable margins						1.50%	1.50%	1.50%	2.25%																																0.50%
Line of credit facility, available borrowing capacity						776,000,000
Letters of credit, outstanding						20,000,000
Scheduled principal payments made											18,000,000	18,000,000	36,000,000	36,000,000	11,000,000	22,000,000
Accounts receivable securitization program credit facility, amount outstanding		130,000,000
Accounts receivable securitization program, additional capacity																																																												145,000,000
Senior notes, maturity date																																																						Oct. 01, 2018			Jun. 30, 2016
Senior notes, repayment terms																																																						Payable semiannually in arrears on April 1st and October 1st of each year			Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year
Treasury rate plus, basis points																																																					0.50%
Line of credit facility additional borrowing capacity																																																										150,000,000
Fair value of debt		3,150,000,000
Long-term debt		3,070,311,000			3,209,762,000
Number of additional forward starting interest rate swaps	6			4
Notional amount of interest rate cash flow hedges																																425,000,000	225,000,000	100,000,000	25,000,000	75,000,000	600,000,000
Average fixed rate payable on interest rate swap																							1.91%
Fixed rate payable on interest rate swap																								2.50%	1.96%	1.32%	2.38%
Maturity date of interest rate cash flow hedges																								Dec. 01, 2014	Dec. 01, 2013	Dec. 01, 2012	May 01, 2015
Fair value of our interest rate swaps, liability																												$ 16,000,000	$ 24,000,000																																			$ 19,000,000	$ 5,000,000

Commitments and Contingencies - Additional Information (Detail) (USD $)						3 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014 Letters of Credit and Surety Bonds	Jun. 30, 2014 Self Insurance Programs Letters of Credit and Surety Bonds	Jun. 30, 2014 Other Debt Guarantees Letters of Credit and Surety Bonds	Jun. 30, 2013 Professional And General Liability	Dec. 31, 2012 Professional And General Liability	Dec. 31, 2011 Professional And General Liability	Jun. 30, 2014 Location 2	Jun. 30, 2014 Location 1	Jun. 30, 2014 Illinois	Dec. 31, 2013 Illinois	Jun. 30, 2014 Other Current Liabilities	Jun. 30, 2014 Other Current Assets [Member]	Jun. 30, 2014 Wind Storms Minimum	Jun. 30, 2014 Wind Storms Maximum	Jun. 30, 2014 Earthquake	Jun. 30, 2014 Earthquake Maximum	Jun. 30, 2014 Earthquake UNITED STATES Minimum	Jun. 30, 2014 Earthquake UNITED STATES Maximum	Jun. 30, 2014 Earthquake PUERTO RICO	Jun. 30, 2014 Flood Location 2	Jun. 30, 2014 Flood Location 1	Nov. 30, 2010 Subsidiaries Professional Liability Maximum	Nov. 30, 2010 Subsidiaries General Liability Maximum	Jun. 30, 2014 Subsidiaries General and Professional Liability Insurance Policies	Jun. 30, 2014 Subsidiaries General and Professional Liability Insurance Policies Minimum	Jun. 30, 2014 Subsidiaries General and Professional Liability Insurance Policies Maximum	Jun. 30, 2014 Psychiatric Solutions Inc General and Professional Liability Insurance Policies Maximum	Oct. 30, 2012 Behavioral Health Facilities Acquired from Ascend Health Corporation General and Professional Liability Insurance Policies	Oct. 30, 2012 Behavioral Health Facilities Acquired from Ascend Health Corporation General and Professional Liability Insurance Policies Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 204,000,000	$ 206,000,000																						$ 10,000,000	$ 3,000,000				$ 3,000,000		$ 20,000,000
Purchased several excess policies through commercial insurance carriers per occurrence																												250,000,000			250,000,000
Percentage of liability for claims paid under commercially insured coverage																										10.00%
Liability for claims paid under commercially insured coverage																											10,000,000	60,000,000
Minimum Insurance Deductible									250,000	50,000							250,000													25,000
Reduction in professional and general liability self-insurance reserves relating to prior years						65,000,000
Weighting given to company-specific metrics							100.00%	75.00%
General industry metrics							0.00%	25.00%
Self-insured for professional and general liability, current	44,000,000	44,000,000
Compensation liability claims	64,000,000	64,000,000
Compensation and related benefits	34,000,000	34,000,000
Commercial property insurance policies covering catastrophic losses																1,000,000,000		250,000,000		100,000,000	25,000,000
Percentage of insurance deductible															3.00%	5.00%			1.00%	5.00%
Maximum insurance deductible																					25,000	250,000	500,000
Accounts receivable, net	1,186,012,000	1,116,961,000									28,000,000	49,000,000
Accounts receivable net greater than sixty days Past due											5,000,000	28,000,000
Accounts receivable											32,000,000	46,000,000
Off-balance sheet contingent obligation			94,000,000	73,000,000	21,000,000
Estimated reserve													25,000,000
Commercial insurance recoveries														$ 20,000,000

Segment Reporting (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Segment Reporting Information [Line Items]
Gross inpatient revenues	$ 5,410,821	$ 4,919,537	$ 10,896,084	$ 10,002,955
Gross outpatient revenues	2,280,891	1,912,528	4,431,011	3,760,753
Total net revenues	2,019,821	1,834,975	3,939,987	3,666,607
Income/(loss) before allocation of corporate overhead and income taxes	258,345	265,818	494,128	469,802
Allocation of corporate overhead	0	0	0	0
Income/(loss) after allocation of corporate overhead and before income taxes	258,345	265,818	494,128	469,802
Total assets	8,548,072	8,317,253	8,548,072	8,317,253	8,311,723
Acute Care Hospital Services
Segment Reporting Information [Line Items]
Gross inpatient revenues	3,724,309	3,321,154	7,600,673	6,828,424
Gross outpatient revenues	2,068,076	1,708,200	4,025,567	3,359,775
Total net revenues	1,024,011	894,639	1,995,400	1,803,373
Income/(loss) before allocation of corporate overhead and income taxes	118,345	118,390	229,994	199,019
Allocation of corporate overhead	(44,693)	(46,109)	(89,390)	(92,221)
Income/(loss) after allocation of corporate overhead and before income taxes	73,652	72,281	140,604	106,798
Total assets	3,319,048	3,126,223	3,319,048	3,126,223
Behavioral Health Services
Segment Reporting Information [Line Items]
Gross inpatient revenues	1,686,512	1,598,383	3,295,411	3,174,531
Gross outpatient revenues	204,480	193,703	388,595	379,505
Total net revenues	992,348	929,470	1,937,805	1,839,014
Income/(loss) before allocation of corporate overhead and income taxes	243,540	240,556	464,688	461,331
Allocation of corporate overhead	(23,136)	(22,461)	(49,305)	(44,828)
Income/(loss) after allocation of corporate overhead and before income taxes	220,404	218,095	415,383	416,503
Total assets	4,995,534	4,919,566	4,995,534	4,919,566
Other
Segment Reporting Information [Line Items]
Gross outpatient revenues	8,335	10,625	16,849	21,473
Total net revenues	3,462	10,866	6,782	24,220
Income/(loss) before allocation of corporate overhead and income taxes	(103,540)	(93,128)	(200,554)	(190,548)
Allocation of corporate overhead	67,829	68,570	138,695	137,049
Income/(loss) after allocation of corporate overhead and before income taxes	(35,711)	(24,558)	(61,859)	(53,499)
Total assets	$ 233,490	$ 271,464	$ 233,490	$ 271,464

Computation of Basic and Diluted Earnings per Share (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Basic and Diluted:
Net income attributable to UHS	$ 151,671	$ 151,841	$ 289,749	$ 271,625
Less: Net income attributable to unvested restricted share grants	(77)	(88)	(147)	(157)
Net income attributable to UHS - basic and diluted	$ 151,594	$ 151,753	$ 289,602	$ 271,468
Weighted average number of common shares-basic	98,872	98,033	98,722	97,872
Net effect of dilutive stock options and grants based on the treasury stock method	1,363	1,178	1,474	1,019
Weighted average number of common shares and equivalents-diluted	100,235	99,211	100,196	98,891
Earnings per basic share attributable to UHS	$ 1.53	$ 1.55	$ 2.93	$ 2.77
Earnings per diluted share attributable to UHS	$ 1.51	$ 1.53	$ 2.89	$ 2.75

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Earnings Per Share Data ("EPS") and Stock Based Compensation - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive weighted average stock options excluded from computation of earnings per share	0	0	0	0
Unrecognized compensation cost related to unvested options and restricted stock	$ 64,800,000		$ 64,800,000
Unrecognized compensation cost, remaining weighted average vesting period in years			2 years 10 months 24 days
Stock options granted during period (net of cancellations)			2,746,500
Weighted-average grant date fair value, per share			$ 17.13
Stock-based compensation expense			14,945,000	13,579,000
Excess tax benefit from share based compensation			28,493,000	15,085,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	7,400,000	6,100,000	14,200,000	12,800,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized	$ 358,000	$ 307,000	$ 648,000	$ 712,000

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References+ Details

Dispositions and Acquisitions - Additional Information (Detail) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Significant Acquisitions and Disposals [Line Items]
Cash paid/reserved related to acquisition of property and businesses	$ 71,000,000	$ 1,320,000
Aggregate cash proceeds from divestiture of businesses	11,000,000	34,000,000
Pre-tax gain proceeds from divestiture of businesses	$ 10,000,000
Arbor Group, L.L.C
Significant Acquisitions and Disposals [Line Items]
Number of management contracts	3
Number of beds	66
Psychiatric Institute
Significant Acquisitions and Disposals [Line Items]
Number of beds	124
Palo Verde Behavioral Health
Significant Acquisitions and Disposals [Line Items]
Number of beds	48
Previously Closed Facilities
Significant Acquisitions and Disposals [Line Items]
Number of facilities		3
Peak Behavioral Health Services
Significant Acquisitions and Disposals [Line Items]
Number of acute care hospital beds included in sale		104

Dividends - Additional Information (Detail) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended		1 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jul. 31, 2014 Subsequent Event
Dividends [Line Items]
Dividends declared and paid, per share	$ 0.05	$ 0.05
Dividends declared and paid	$ 5.0	$ 4.9	$ 9.9	$ 9.8
Authorized share price increased					$ 0.05
Quarterly cash dividend					$ 0.10
Dividend payable date					Sep. 16, 2014
Dividend record date					Sep. 02, 2014

Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jan. 01, 2014
Income Taxes [Line Items]
Unrecognized tax benefits		$ 3
Impact of unrecognized tax benefits if recognized		2
Jurisdictions statutes of limitations expiration period	12 months
Period of expiration of the statute of limitations for certain jurisdictions	Within the next twelve months
Minimum
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	3 years
Maximum
Income Taxes [Line Items]
Accrued interest and penalties	$ 1
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	4 years

Supplemental Condensed Consolidating Statements of Income (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	$ 2,195,776	$ 2,081,662	$ 4,324,126	$ 4,160,010
Less: Provision for doubtful accounts	175,955	246,687	384,139	493,403
Net revenues	2,019,821	1,834,975	3,939,987	3,666,607
Operating charges:
Salaries, wages and benefits	961,920	897,334	1,897,285	1,799,630
Other operating expenses	428,720	325,562	810,480	706,569
Supplies expense	223,774	202,344	439,572	406,986
Depreciation and amortization	90,691	81,682	184,050	161,494
Lease and rental expense	23,458	24,082	46,796	48,747
Electronic health records incentive income	(2,174)	(83)	(2,604)	(4,795)
Operating expenses	1,726,389	1,530,921	3,375,579	3,118,631
Income from operations	293,432	304,054	564,408	547,976
Interest expense	35,087	38,236	70,280	78,174
Interest (income) expense, affiliate	0	0	0	0
Equity in net income of consolidated affiliates	0	0	0	0
Income before income taxes	258,345	265,818	494,128	469,802
Provision for income taxes	91,731	98,015	175,662	172,064
Net income	166,614	167,803	318,466	297,738
Less: Income attributable to noncontrolling interests	14,943	15,962	28,717	26,113
Net income attributable to UHS	151,671	151,841	289,749	271,625
Parent
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	0	0	0	0
Less: Provision for doubtful accounts	0	0	0	0
Net revenues	0	0	0	0
Operating charges:
Salaries, wages and benefits	0	0	0	0
Other operating expenses	0	0	0	0
Supplies expense	0	0	0	0
Depreciation and amortization	0	0	0	0
Lease and rental expense	0	0	0	0
Electronic health records incentive income	0	0	0	0
Operating expenses	0	0	0	0
Income from operations	0	0	0	0
Interest expense	33,589	36,772	67,162	74,718
Interest (income) expense, affiliate	0	0	0	0
Equity in net income of consolidated affiliates	(172,404)	(174,539)	(331,205)	(317,745)
Income before income taxes	138,815	137,767	264,043	243,027
Provision for income taxes	(12,856)	(14,074)	(25,706)	(28,598)
Net income	151,671	151,841	289,749	271,625
Less: Income attributable to noncontrolling interests	0	0	0	0
Net income attributable to UHS	151,671	151,841	289,749	271,625
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	1,520,223	1,416,011	2,984,143	2,837,863
Less: Provision for doubtful accounts	121,531	150,294	257,517	300,062
Net revenues	1,398,692	1,265,717	2,726,626	2,537,801
Operating charges:
Salaries, wages and benefits	688,041	639,421	1,357,294	1,285,015
Other operating expenses	283,869	193,388	524,045	437,807
Supplies expense	136,754	123,894	268,229	252,604
Depreciation and amortization	64,622	57,597	132,336	113,376
Lease and rental expense	14,444	15,536	28,793	31,211
Electronic health records incentive income	(1,704)	(452)	(2,134)	(3,568)
Operating expenses	1,186,026	1,029,384	2,308,563	2,116,445
Income from operations	212,666	236,333	418,063	421,356
Interest expense	1,147	846	1,971	1,700
Interest (income) expense, affiliate	22,112	24,391	44,224	48,782
Equity in net income of consolidated affiliates	(49,911)	(38,497)	(92,863)	(70,278)
Income before income taxes	239,318	249,593	464,731	441,152
Provision for income taxes	84,448	93,570	163,201	158,893
Net income	154,870	156,023	301,530	282,259
Less: Income attributable to noncontrolling interests	0	0	0	0
Net income attributable to UHS	154,870	156,023	301,530	282,259
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	683,074	672,949	1,354,661	1,336,155
Less: Provision for doubtful accounts	54,424	96,393	126,622	193,341
Net revenues	628,650	576,556	1,228,039	1,142,814
Operating charges:
Salaries, wages and benefits	273,879	257,913	539,991	514,615
Other operating expenses	151,927	139,063	300,452	282,266
Supplies expense	87,020	78,450	171,343	154,382
Depreciation and amortization	26,069	24,085	51,714	48,118
Lease and rental expense	9,459	8,955	18,664	18,040
Electronic health records incentive income	(470)	369	(470)	(1,227)
Operating expenses	547,884	508,835	1,081,694	1,016,194
Income from operations	80,766	67,721	146,345	126,620
Interest expense	351	618	1,147	1,756
Interest (income) expense, affiliate	(22,112)	(24,391)	(44,224)	(48,782)
Equity in net income of consolidated affiliates	0	0	0	0
Income before income taxes	102,527	91,494	189,422	173,646
Provision for income taxes	20,139	18,519	38,167	41,769
Net income	82,388	72,975	151,255	131,877
Less: Income attributable to noncontrolling interests	14,943	15,962	28,717	26,113
Net income attributable to UHS	67,445	57,013	122,538	105,764
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts	(7,521)	(7,298)	(14,678)	(14,008)
Less: Provision for doubtful accounts	0	0	0	0
Net revenues	(7,521)	(7,298)	(14,678)	(14,008)
Operating charges:
Salaries, wages and benefits	0	0	0	0
Other operating expenses	(7,076)	(6,889)	(14,017)	(13,504)
Supplies expense	0	0	0	0
Depreciation and amortization	0	0	0	0
Lease and rental expense	(445)	(409)	(661)	(504)
Electronic health records incentive income	0	0	0	0
Operating expenses	(7,521)	(7,298)	(14,678)	(14,008)
Income from operations	0	0	0	0
Interest expense	0	0	0	0
Interest (income) expense, affiliate	0	0	0	0
Equity in net income of consolidated affiliates	222,315	213,036	424,068	388,023
Income before income taxes	(222,315)	(213,036)	(424,068)	(388,023)
Provision for income taxes	0	0	0	0
Net income	(222,315)	(213,036)	(424,068)	(388,023)
Less: Income attributable to noncontrolling interests	0	0	0	0
Net income attributable to UHS	$ (222,315)	$ (213,036)	$ (424,068)	$ (388,023)

Supplemental Condensed Consolidating Comprehensive Income (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Comprehensive Income (Loss) [Line Items]
Net income	$ 166,614	$ 167,803	$ 318,466	$ 297,738
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	4,465	5,282	8,210	9,817
Amortization of terminated hedge	(84)	(84)	(168)	(168)
Other comprehensive income (loss) before tax	4,381	5,198	8,042	9,649
Income tax (benefit) expense related to items of other comprehensive income	1,620	1,960	2,974	3,638
Total other comprehensive income, net of tax	2,761	3,238	5,068	6,011
Comprehensive income	169,375	171,041	323,534	303,749
Less: Comprehensive income attributable to noncontrolling interests	14,943	15,962	28,717	26,113
Comprehensive income attributable to UHS	154,432	155,079	294,817	277,636
Parent
Comprehensive Income (Loss) [Line Items]
Net income	151,671	151,841	289,749	271,625
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	4,465	5,282	8,210	9,817
Amortization of terminated hedge	(84)	(84)	(168)	(168)
Other comprehensive income (loss) before tax	4,381	5,198	8,042	9,649
Income tax (benefit) expense related to items of other comprehensive income	1,620	1,960	2,974	3,638
Total other comprehensive income, net of tax	2,761	3,238	5,068	6,011
Comprehensive income	154,432	155,079	294,817	277,636
Less: Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to UHS	154,432	155,079	294,817	277,636
Guarantors
Comprehensive Income (Loss) [Line Items]
Net income	154,870	156,023	301,530	282,259
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0	0	0
Amortization of terminated hedge	0	0	0	0
Other comprehensive income (loss) before tax	0	0	0	0
Income tax (benefit) expense related to items of other comprehensive income	0	0	0	0
Total other comprehensive income, net of tax	0	0	0	0
Comprehensive income	154,870	156,023	301,530	282,259
Less: Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to UHS	154,870	156,023	301,530	282,259
Non Guarantors
Comprehensive Income (Loss) [Line Items]
Net income	82,388	72,975	151,255	131,877
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0	0	0
Amortization of terminated hedge	0	0	0	0
Other comprehensive income (loss) before tax	0	0	0	0
Income tax (benefit) expense related to items of other comprehensive income	0	0	0	0
Total other comprehensive income, net of tax	0	0	0	0
Comprehensive income	82,388	72,975	151,255	131,877
Less: Comprehensive income attributable to noncontrolling interests	14,943	15,962	28,717	26,113
Comprehensive income attributable to UHS	67,445	57,013	122,538	105,764
Consolidating Adjustments
Comprehensive Income (Loss) [Line Items]
Net income	(222,315)	(213,036)	(424,068)	(388,023)
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges	0	0	0	0
Amortization of terminated hedge	0	0	0	0
Other comprehensive income (loss) before tax	0	0	0	0
Income tax (benefit) expense related to items of other comprehensive income	0	0	0	0
Total other comprehensive income, net of tax	0	0	0	0
Comprehensive income	(222,315)	(213,036)	(424,068)	(388,023)
Less: Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to UHS	$ (222,315)	$ (213,036)	$ (424,068)	$ (388,023)

Supplemental Condensed Consolidating Balance Sheet (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 14,732	$ 17,238	$ 12,558	$ 23,471
Accounts receivable, net	1,186,012	1,116,961
Supplies	104,280	101,781
Deferred income taxes	107,359	119,903
Other current assets	117,498	76,446
Total current assets	1,529,881	1,432,329
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	5,901,163	5,691,902
Less: accumulated depreciation	(2,386,484)	(2,249,733)
Property, Plant and Equipment, Net	3,514,679	3,442,169
Other assets:
Goodwill	3,089,172	3,049,016
Deferred charges	48,976	57,881
Other	365,364	330,328
Total assets	8,548,072	8,311,723	8,317,253
Current liabilities:
Current maturities of long-term debt	77,686	99,312
Accounts payable and accrued liabilities	1,038,187	953,449
Federal and state taxes	0	7,127
Total current liabilities	1,115,873	1,059,888
Intercompany payable	0	0
Other noncurrent liabilities	276,462	284,589
Long-term debt	3,070,311	3,209,762
Intercompany note payable	0	0
Deferred income taxes	254,573	239,148
Redeemable noncontrolling interests	231,545	218,107
UHS common stockholders' equity	3,546,134	3,249,979
Noncontrolling interest	53,174	50,250
Total equity	3,599,308	3,300,229
Liabilities and Equity, Total	8,548,072	8,311,723
Parent
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	63,667	76,719
Other current assets	0	0
Total current assets	63,667	76,719
Investments in subsidiaries	6,709,704	6,378,499
Intercompany receivable	51,457	226,592
Intercompany note receivable	0	0
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	40,985	49,866
Other	7,392	8,411
Total assets	6,873,205	6,740,087
Current liabilities:
Current maturities of long-term debt	75,803	97,403
Accounts payable and accrued liabilities	25,038	28,099
Federal and state taxes	0	4,963
Total current liabilities	100,841	130,465
Intercompany payable	0	0
Other noncurrent liabilities	2,311	7,591
Long-term debt	3,024,627	3,168,819
Intercompany note payable	0	0
Deferred income taxes	199,292	183,233
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	3,546,134	3,249,979
Noncontrolling interest	0	0
Total equity	3,546,134	3,249,979
Liabilities and Equity, Total	6,873,205	6,740,087
Guarantors
Current assets:
Cash and cash equivalents	4,530	7,990	3,570	11,949
Accounts receivable, net	825,120	799,898
Supplies	65,008	63,562
Deferred income taxes	43,692	43,184
Other current assets	103,085	63,786
Total current assets	1,041,435	978,420
Investments in subsidiaries	1,569,774	1,476,911
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	4,256,178	4,093,914
Less: accumulated depreciation	(1,579,351)	(1,478,758)
Property, Plant and Equipment, Net	2,676,827	2,615,156
Other assets:
Goodwill	2,589,121	2,552,190
Deferred charges	5,469	5,577
Other	294,755	251,365
Total assets	8,177,381	7,879,619
Current liabilities:
Current maturities of long-term debt	1,052	916
Accounts payable and accrued liabilities	901,868	837,354
Federal and state taxes	0	2,164
Total current liabilities	902,920	840,434
Intercompany payable	557,113	758,003
Other noncurrent liabilities	196,428	199,104
Long-term debt	20,970	5,337
Intercompany note payable	1,104,881	982,568
Deferred income taxes	55,281	55,915
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	5,339,788	5,038,258
Noncontrolling interest	0	0
Total equity	5,339,788	5,038,258
Liabilities and Equity, Total	8,177,381	7,879,619
Non Guarantors
Current assets:
Cash and cash equivalents	10,202	9,248	8,988	11,522
Accounts receivable, net	360,892	317,063
Supplies	39,272	38,219
Deferred income taxes	0	0
Other current assets	14,413	12,660
Total current assets	424,779	377,190
Investments in subsidiaries	0	0
Intercompany receivable	505,656	531,411
Intercompany note receivable	1,104,881	982,568
Property and equipment	1,644,985	1,597,988
Less: accumulated depreciation	(807,133)	(770,975)
Property, Plant and Equipment, Net	837,852	827,013
Other assets:
Goodwill	500,051	496,826
Deferred charges	2,522	2,438
Other	63,217	70,552
Total assets	3,438,958	3,287,998
Current liabilities:
Current maturities of long-term debt	831	993
Accounts payable and accrued liabilities	111,281	87,996
Federal and state taxes	0	0
Total current liabilities	112,112	88,989
Intercompany payable	0	0
Other noncurrent liabilities	77,723	77,894
Long-term debt	24,714	35,606
Intercompany note payable	0	0
Deferred income taxes	0	0
Redeemable noncontrolling interests	231,545	218,107
UHS common stockholders' equity	2,939,690	2,817,152
Noncontrolling interest	53,174	50,250
Total equity	2,992,864	2,867,402
Liabilities and Equity, Total	3,438,958	3,287,998
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	0	0
Other current assets	0	0
Total current assets	0	0
Investments in subsidiaries	(8,279,478)	(7,855,410)
Intercompany receivable	(557,113)	(758,003)
Intercompany note receivable	(1,104,881)	(982,568)
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property, Plant and Equipment, Net	0	0
Other assets:
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(9,941,472)	(9,595,981)
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Federal and state taxes	0	0
Total current liabilities	0	0
Intercompany payable	(557,113)	(758,003)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Intercompany note payable	(1,104,881)	(982,568)
Deferred income taxes	0	0
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	(8,279,478)	(7,855,410)
Noncontrolling interest	0	0
Total equity	(8,279,478)	(7,855,410)
Liabilities and Equity, Total	$ (9,941,472)	$ (9,595,981)

Supplemental Condensed Consolidating Statements of Cash flows (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ 458,416	$ 390,917
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(186,786)	(175,944)
Proceeds received from sale of assets and businesses	11,450	34,008
Cash paid/reserved related to acquisition of property and businesses	(71,000)	(1,320)
Costs incurred for purchase and implementation of electronic health records application	(8,399)	(33,396)
Net cash provided by (used in) investing activities	(254,735)	(176,652)
Cash Flows from Financing Activities:
Reduction of long-term debt	(179,126)	(196,096)
Additional borrowings	0	11,000
Repurchase of common shares	(35,773)	(21,373)
Dividends paid	(9,884)	(9,795)
Issuance of common stock	3,287	2,735
Excess income tax benefits related to stock-based compensation	28,493	15,085
Profit distributions to noncontrolling interests	(13,184)	(26,734)
Changes in intercompany balances with affiliates, net	0	0
Net cash (used in) provided by financing activities	(206,187)	(225,178)
(Decrease) increase in cash and cash equivalents	(2,506)	(10,913)
Cash and cash equivalents, beginning of period	17,238	23,471
Cash and cash equivalents, end of period	14,732	12,558
Parent
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	6,497	929
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0
Proceeds received from sale of assets and businesses	0	0
Cash paid/reserved related to acquisition of property and businesses	0	0
Costs incurred for purchase and implementation of electronic health records application	0	0
Net cash provided by (used in) investing activities	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	(167,755)	(189,188)
Additional borrowings		11,000
Repurchase of common shares	(35,773)	(21,373)
Dividends paid	(9,884)	(9,795)
Issuance of common stock	3,287	2,735
Excess income tax benefits related to stock-based compensation	28,493	15,085
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	175,135	190,607
Net cash (used in) provided by financing activities	(6,497)	(929)
(Decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	256,770	242,016
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(116,688)	(133,607)
Proceeds received from sale of assets and businesses	11,450	7,552
Cash paid/reserved related to acquisition of property and businesses	(67,699)	(1,320)
Costs incurred for purchase and implementation of electronic health records application	(8,399)	(33,396)
Net cash provided by (used in) investing activities	(181,336)	(160,771)
Cash Flows from Financing Activities:
Reduction of long-term debt	(317)	(526)
Additional borrowings		0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Excess income tax benefits related to stock-based compensation	0	0
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	(78,577)	(89,098)
Net cash (used in) provided by financing activities	(78,894)	(89,624)
(Decrease) increase in cash and cash equivalents	(3,460)	(8,379)
Cash and cash equivalents, beginning of period	7,990	11,949
Cash and cash equivalents, end of period	4,530	3,570
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	195,149	147,972
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(70,098)	(42,337)
Proceeds received from sale of assets and businesses	0	26,456
Cash paid/reserved related to acquisition of property and businesses	(3,301)	0
Costs incurred for purchase and implementation of electronic health records application	0	0
Net cash provided by (used in) investing activities	(73,399)	(15,881)
Cash Flows from Financing Activities:
Reduction of long-term debt	(11,054)	(6,382)
Additional borrowings		0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Excess income tax benefits related to stock-based compensation	0	0
Profit distributions to noncontrolling interests	(13,184)	(26,734)
Changes in intercompany balances with affiliates, net	(96,558)	(101,509)
Net cash (used in) provided by financing activities	(120,796)	(134,625)
(Decrease) increase in cash and cash equivalents	954	(2,534)
Cash and cash equivalents, beginning of period	9,248	11,522
Cash and cash equivalents, end of period	10,202	8,988
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0
Proceeds received from sale of assets and businesses	0	0
Cash paid/reserved related to acquisition of property and businesses	0	0
Costs incurred for purchase and implementation of electronic health records application	0	0
Net cash provided by (used in) investing activities	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	0	0
Additional borrowings		0
Repurchase of common shares	0	0
Dividends paid	0	0
Issuance of common stock	0	0
Excess income tax benefits related to stock-based compensation	0	0
Profit distributions to noncontrolling interests	0	0
Changes in intercompany balances with affiliates, net	0	0
Net cash (used in) provided by financing activities	0	0
(Decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$ 0	$ 0

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) (Guarantors)	Jun. 30, 2014
Guarantors
Supplementary Information [Line Items]
Percentage of ownership interests	100.00%